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Studies have highlighted an association between food allergies and 
neuropsychiatric disorders such as anxiety, depression, and attention deficit hyperactivity 
disorder. Though the precise mechanism behind this relationship is unknown, it marks a 
potential novel therapeutic strategy outside of traditional neuropharmacological 
intervention. Food allergy is a heterogeneous disorder of the immune system 
characterized by an immune response that occurs reproducibly to a given food. Chronic 
allergen exposure in patients with mild or non-anaphylactic food allergies may cause or 
exacerbate psychiatric conditions. However, the variability in food allergies due to 
factors like genetic background introduces selection bias for individuals with overt 
anaphylactic reactions. To elucidate the framework of a mechanism by which peripheral 
non-anaphylactic food allergies cause behavioral changes, we sensitized mice to the 
cow’s milk allergen β-lactoglobulin (BLG). This dissertation consists of three studies to 
characterize the behavioral effects of mild cow’s milk allergy (CMA) and the underlying 
mechanism. The first study was to profile the behavioral symptoms of mice following 
sensitization to BLG and their underlying brain pathology. The second builds upon the 
findings of the first, to investigate changes in the brain using RNA sequencing and 
further histological analysis to understand what is happening in the brains of allergic 
mice. The third study compares two strains of mice with different genetic backgrounds 
and their responses to allergic sensitization. We evaluate the difference in their clinical 
symptoms, behavior, microbiomes, and released immune mediators in response to 
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allergic challenge to investigate how genetic predisposition influences the effects we 
observed in our model. 
In study 1, male C57BL/6J mice sensitized to BLG presented increased anxiety-
like behavior in the elevated-zero maze and grooming behavior tests and depression-like 
behavior during the tail-suspension test 24-48 hrs following allergic challenge. Since the 
mice sensitized to BLG were confirmed to be allergic based upon the abundance of BLG-
specific IgE and IgG1, we histologically analyzed their intestines as the primary site of 
insult for CMA. In the ileum region of the small intestine, we observed a decrease in the 
tight junction protein occludin in BLG sensitized mice. A decrease in the abundance of 
occludin is common in intestinal inflammation and often leads to dysfunction of normal 
gut barrier function. Knowing male mice sensitized to BLG had a behavioral change, gut 
pathology, and were confirmed allergic, we then looked for evidence of brain pathology. 
We evaluated the status of astrocytes within the brain by staining for their structural 
protein glial fibrillary acidic protein (GFAP). We found that astrocytes in the substantia 
nigra were hypertrophic, and there was evidence of perivascular glial scarring which is 
common in neuroinflammatory conditions. The perivascular scarring also coincided with 
increased abundance of the proinflammatory cytokine, tumor necrosis factor-alpha 
(TNFα), which astrocytes both respond to and produce when activated. Together these 
data suggest CMA leads to anxiety and depression-like behavior in male mice and that 
the astrocyte response and signaling of cytokines like TNFα are involved in these 
behavioral changes. 
In the second study, we investigate region transcriptional profiles of BLG 
sensitized C57BL/6J male mice. Across the multiple brain regions, using ingenuity 
xx 
 
pathway analysis, we found pathways involved in inflammatory signaling, neuronal 
signaling, cell structural pathways, and disease states differentially activated in BLG 
sensitized mice. We validated some of our findings histologically using myelin basic 
protein (MBP) and IgG as targets based upon our previous glial findings and pathways 
involved in other glial cells and blood-brain barrier integrity. We observed no evidence of 
differential myelination through MBP in the brains of BLG sensitized mice but increased 
extravascular IgG in the brain parenchyma. High amounts of IgG staining within the 
brain implies impairment of normal blood-brain barrier function, which coincides with 
our previous astrocyte data. 
In study 3, we compared the C57BL/6J and BALB/cJ strains because of their 
genetic differences in the allergy response. The differences were apparent when 
observing the overt anaphylactic response to BLG challenge; only the BALB/cJ mice 
showed significant clinical symptoms. However, both strains produced BLG-specific IgE 
in response to treatment, but only the BALB/cJ strain produced IgG antibodies. Despite 
the described differences, males of both strains demonstrated similar anxiety-like 
behavior though the changes were more pronounced in C57BL/6J mice. Knowing the 
differences in immune responses observed in these strains, we quantified the cytokines 
released into the plasma, finding increases in a Th2 cytokines interleukin (IL)-10, -13, 
and -21, in addition to various chemokines in male C57BL/6J mice, but no increases in 
male BALB/cJ mice. Based on the observed differences, we wanted to investigate the 
impact BLG-sensitization had on the microbiome. Both strains were found to have 
distinct profiles, and BLG-sensitization led to strain-specific changes in the microbiome. 
Despite vastly different microbiome profiles, when we performed brain-specific pathway 
xxi 
 
analysis of the microbiomes, the two strains had similar activation states of serotonergic, 





This dissertation focuses on the systemic effects of mild cow's milk allergy 
(CMA). CMA and other allergic hypersensitivities are broader in classification than many 
realize, with some patients expressing mildly or asymptomatically. Existing evidence 
recognizes that populations of mild or asymptomatic patients are less likely to be 
formally diagnosed and exclude the allergens from their diet. In addition to the classic 
symptoms of allergy, CMA and other allergic diseases are found to be comorbid with 
various behavioral and neuropsychiatric conditions. With increasing numbers of patients 
resistant to neuropharmacological approaches for behavioral and neuropsychiatric 
disorders, increases in the diagnosis of mental disorders may be driven by these acute 
non-anaphylactic allergic disorders.  
For this dissertation, three studies were conducted involving a non-anaphylactic 
CMA model and characterizing the impact of the disease on the peripheral immune 
system and the central nervous system (CNS). The first study examined the behavioral, 
gut, and brain pathology in C57BL/6J mice resulting from sensitization and challenge 
with a major milk allergy: β-lactoglobulin (BLG; Bos d 5), to assess the hypothesis that 
sensitization of mice to a milk allergen would cause changes in the CNS leading to 
changes in behavior. In the second study with our C57BL/6J model of CMA, we assayed 
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the intestinal permeability, performed brain RNAseq, and further evaluated the brain 
pathology to elucidate mechanisms of behavioral changes, specifically highlighting 
neuroinflammatory, demyelination, and blood-brain barrier integrity-based effects. The 
third study compared CMA-induced changes in behavior, peripheral immune factors, and 
gut microbiota profiles in two genetically distinct mouse strains. Each result chapter 
corresponding to each study provides additional introductory material to that study. 
Food Allergy 
Definition 
The concept of allergy is ancient in the context of human history. Our knowledge 
of allergy goes back millennia; our oldest records date to 1000-2000 BCE China 
describing a "plant fever" occurring in autumn (Ring, 2014). The term "allergy" was first 
coined in the early 20th century by Austrian pediatrician Clemons von Pirquet circa 1906. 
Pirquet is quoted as stating, "The conception that antibodies, which should protect 
against disease, are also responsible for disease, sounds at first absurd." highlighting 
what was at the time a massive gap in our understanding of disease and immunity. 
Pirquet described allergy as an altered reactivity induced by what he called an "allergen," 
defined as a foreign substance (Silverstein, 2000). Our modern definition of food allergy, 
similar to Pirquet's, an adverse health effect arising from a specific immune response that 
occurs reproducibly on exposure to a given food (Boyce et al., 2010). Allergy is 
characterized as a hypersensitivity disorder; the term "hypersensitivity" describes a broad 
spectrum of similar conditions, in which case the typical immune tolerance to benign 
environmental factors is disrupted, reproducibly provoking an undesired immune 
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response (Boyce et al., 2010). Allergies by classical definition are type I hypersensitivity, 
meaning it is mediated by antibodies of the immunoglobulins (Ig) E isotype. Food allergy 
by this understanding is an inappropriate IgE-mediated response to specific dietary 
proteins. 
Prevalence 
 The prevalence of food allergy varies wildly depending on detection methods and 
the studied population. Prevalence is subjected to change based on factors such as sex, 
age, ethnicity, and socioeconomic status; therefore, specific populations are at higher 
risks for developing allergy and increased severity (Rudders et al., 2014; Acker et al., 
2017; Gupta et al., 2018; Willits et al., 2018). Several genetic factors involved in 
establishing T helper type 2 (Th2) immunity have been identified as increasing the odds 
of developing allergic disease, including interleukin (IL)-4, -10, -13, and specific human 
leukocyte antigen (HLA) haplogroups (Howell et al., 1998; Liu et al., 2004; Campos 
Alberto et al., 2008; Hong et al., 2009). Overall, in the United States, food allergy afflicts 
3-10% of the population (Gupta et al., 2019).  
Impact on Health and Quality of Life 
Childhood food allergy is an incredible burden on the individual, family, and 
economy. Out-of-pocket medical costs for continued treatment, lifestyle changes, and 
emergency medical services are surface-level costs that all families typically experience 
but do not capture the disease's full impact. Dr. Ruchi Gupta estimated in 2013 that $5.5 
billion was lost due to out-of-pocket treatment costs for services like preventative 
measures in the form of special diets, emergency or regular anti-allergy drugs like 
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antihistamines and EpiPens, and emergency room visits. The cost equates to 
$931/child/year in 2013 or $1051 if adjusted for inflation to the year this dissertation is 
published (U.S. Bureau of Labor Statistics). The addition of the costs required to 
maintain allergic children's safety and health is substantial and increases the economic 
hardship on families and can be particularly devastating in communities already 
struggling with poverty. The personal burdens in conjunction with economic costs lead to 
a total $24.7 billion cost to the U.S. economy or $27.9 billion estimated for 2021 (Gupta 
et al., 2013).  
In addition to the direct economic burden of maintaining a lifestyle safe for a 
child with food allergies, other factors such as those on social and mental burdens are 
important. Families of children with allergies often cite the most common issues: the 
need for special food, increased time preparing and shopping for food, increased time 
preparing for school, and inhibitions on social life (Bilaver et al., 2016). A Swedish study 
compared case-control pairings to evaluate the different economic and intangible costs to 
a household with a food allergic child. Parents/guardians of children with food allergies 
were more likely to report feeling restricted in their career and feelings of anger, fear, 
anxiety, and trauma than control families. Also, parents/guardians reported children with 
food allergies to be restricted in their social life and more prone to feelings of anger, fear, 
feeling left out, and trauma, and are considered in poor health (Wai et al., 2019). These 
factors serve as a simplified estimation of the challenges families of children with food 
allergies face.
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Symptoms of Food Allergy 
Types and Severity 
Food allergy is known to cause a spectrum of symptoms ranging in severity. The 
symptoms can range from the localized inflammation and disruption of the gut to 
systemic anaphylactic shock symptoms. Symptoms can be broadly fit into four 
categories: gastrointestinal, skin irritation, respiratory distress, and cardiovascular 
dysfunction (du Toit et al., 2010; Burks et al., 2012; Mousan and Kamat, 2016). The less 
severe symptoms are often considered those involving the gut and skin, whereas 
respiratory and cardiovascular symptoms often are signs of a life-threatening response. 
In the gut, commonly identified symptoms include diarrhea, nausea, discomfort, 
and vomiting. Symptoms in the gut can occur in conjunction with other symptoms or, in 
some cases, isolation. Gastrointestinal symptoms typically can be the mildest symptoms 
or misdiagnosed as other gastrointestinal diseases. Skin irritation is a likely second 
identifying symptom, and for health care providers is the most visible condition. Allergic 
inflammation can manifest on the skin in the form of hives and swelling. The swelling is 
sometimes observed in the throat, lips, and tongue leading to difficulty swallowing or 
speech impairment due to the disruption of the vocal folds, larynx, and other resonant 
structures. The swelling is occasionally paired with paresthetic sensations around the 
mouth and throat.  
Respiratory and cardiovascular symptoms are often the most severe symptoms. 
Typically, in the respiratory tract, apparent inflammation will cause wheezing, difficulty 
breathing, and chest tightness. These are often paired with cardiovascular symptoms, 
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often showing a rapid heart rate, drop in blood pressure, and dizziness. If left unchecked 
with emergency epinephrine injection, severe respiratory and cardiovascular symptoms 
will often lead to shock, loss of consciousness, and death.  
 In addition to the apparent clinical pathology caused by food allergies, there are 
often many other accompanying symptoms. For example, patients often site before 
symptom onset, sometimes immediately after accidental allergen exposure, feeling 
anxious or a lingering sense of doom or dread. Though somewhat ubiquitous, these 
feelings can sometimes serve as an early indicator of imminent allergic attack in patients 
with clear clinical history. Together these symptoms make up what is known about the 
spectrum of allergic anaphylaxis indicators, though often found to vary between patients 
in appearance and severity. 
Clinical Diagnosis 
The threshold for diagnosis varies depending on the test and definition used for 
food allergy. The Gupta paper estimates 3-10% of the percentage of the U.S. population 
that has food allergies. However, multiple diagnostic approaches are commonly used in 
cases of food allergy, potentially obfuscating results. Typical diagnostic approaches 
include the skin prick test (SPT) method, allergen-specific IgE positive test, self-
reporting, and food challenge.  
A Meta-analysis by Roberto Rona in 2007 reviewed 934 MEDLINE articles for 
food allergy incidence. From this dataset, it was segregated by aspects like age and 
method of testing for allergy. Self and maternal reports of food allergy tend to be the 
most liberal estimates. The patients and caregivers have the most firsthand experience. 
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Therefore, they are prone to over-identifying any perceived food-induced discomfort as 
an allergy. Thus, diagnosis based on self-reports estimates that between 3% and 35% of 
people are allergic. Some studies in the meta-analysis followed up self-reports with other 
tests like SPT or allergen-specific IgE . The use of secondary validation confirmed that 2-
5% of the population is allergic.  
SPT is a standard method for assessment of allergy using in clinics. The skin is 
punctured with a needle coated with a small amount of the potentially offensive allergen; 
a positive response is when the area swells. The size of the swelling of the region, also 
called a wheal, is typically associated with the allergic reaction severity. Rona's meta-
analysis found that pure assessment via SPT found 7-17% of the population is believed to 
be allergic. 
One of the most important biomarkers for the establishment of allergy is the 
production of allergen-specific IgE. Thus blood-based detection of allergen-specific IgE 
is another commonly used clinical diagnostic method for food allergies. Studies in the 
meta-analysis that used blood-based enzyme-linked immunosorbent assay (ELISA) for 
allergen-specific IgE found an estimated 4-6% of the population is allergic.  
Finally, food challenge-based assessments, including double-blind, placebo-
controlled food challenge (DBPCFC), are common ways of identifying allergic 
individuals. These methods are considered the "gold standard" of diagnosis but are 
considered the most conservative assessment. Studies estimate that 1-10.8% of people are 
allergic in the meta-analysis, which is the lowest bottom range limit (Rona et al., 2007). 
A likely reason for this phenomenon is that DBPCFC tests only identify patients with 
severe allergic reactions and are less likely to identify mild or non-anaphylactic patients. 
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As a result, these tests are prone to underestimate the portion of the population that is 
allergic. Therefore, under the umbrella of allergic individuals, there are subpopulations 
that are highly anaphylactic and more mild or subclinical responders. 
Atypical or Non-anaphylactic Food Allergies 
As previously introduced, allergy is a broad-spectrum disease. Allergy has both 
immediate symptoms in addition to late phase symptoms that arise hours after exposure. 
Due to variation in symptom severity, typical local effects arise from food allergies in the 
gut, but systemic insults are not always present. In the case of CMA specifically, ~31% 
of diagnosed patients have severe responses to the allergen, meaning it is more likely for 
patients to exhibit mild symptoms (Gupta et al., 2011). In contrast, nut allergies are more 
likely to induce severe responses. The variance in symptom presentation shows that some 
food allergies are more likely to be non-anaphylactic and, as a consequence, display 
differing symptoms. 
Even within the framework of the classical definition of reproducible IgE-
mediated immunity, there exist non-IgE mediated aspects of allergy or IgE working in 
concert with other factors causing specific effects.  Historically more emphasis has been 
given to the primarily IgE-mediated immediate reactions of food allergy and less on the 
delayed IgG-mediated response (Hill and Hosking, 1995; Koletzko et al., 2012). The 
over-emphasis of the immediate or IgE response is a problem for certain patient groups; 
for example, it is well documented that CMA patients are more likely to demonstrate a 
delayed response in infancy (Dupont, 2014).  
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Certain symptoms are also more associated with either the IgE or IgG-mediated 
response. For example, we know many of the most severe classical symptoms are 
associated with the IgE-mediated mast cell response. However, many of the gut-
associated pathologies, such as diarrhea, malabsorption, and dysmotility in addition to 
delayed hypotension, can be caused by a non-IgE mediated response (Dupont, 2014; 
Mousan and Kamat, 2016). Similarly, there are food allergy-like symptoms and, 
specifically, non-IgE mediated, associated it neuropsychiatric disorders such as autism. 
(Jyonouchi, 2008, 2009).  
Patients with atypical or non-anaphylactic food allergies often display differing 
symptoms from those with robust IgE-mediated responses. The variance in food allergies 
leads to a variable response in patients depending on the allergen. CMA is one of the 
most likely to generate mild or delayed symptoms. The non-IgE mediated symptoms 
have been focused on less in a clinical setting and often are misdiagnosed. Therefore, if a 
patient lacks a robust anaphylactic response or present more IgG-mediated symptoms 
they are less likely to be diagnosed. 
Development of Type I Hypersensitivity 
Antigen Presentation 
 Professional antigen-presenting cells like dendritic cells and monocytes function 
as bridges between the innate and adaptive immune systems. The antigen presentation 
process is typically initiated in the gut either by disrupting the epithelial barrier, 
transferring allergens by surveillance cells like microfold cells, undigested proteins 
crossing the barrier, or sampling of luminal contents by dendritic cells (Menard et al., 
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2010; McDole et al., 2012; Mabbott et al., 2013). In the lamina propria, a dendritic cell 
will uptake an antigen by phagocytosis and process it into peptides to present on an MHC 
II receptor. The dendritic cell then translocates to gut-associated lymphoid tissue 
structures like Peyer's patches or mesenteric lymph nodes to present the antigen to 
follicular helper (Tfh) or Th2 cells via OX40/OX40L signaling (Liu et al., 2020).  
Once presented to the Tfh cell, the adaptive immune response initiates, and 
antibody production begins. The T cells then stimulate naïve B cells to activate antibody 
production. Antibody production is driven by a single gene subjected to double-stranded 
DNA breakage and recombination based upon secondary cytokine signals. Typically 
naïve B cell produces either IgM or IgD, but in the context of type I hypersensitivity, 
stimulation with IL-4 promotes class switching to IgE (Market and Papavasiliou, 2003). 
To achieve class switching, helper T cells interact with B cells via CD40/CD40L and 
release IL-4. IL-4, when bound to its receptor to induces Janus kinase (JAK)-signal 
transducer and activator of transcription (STAT) signaling, while CD40/CD40L leads to 
the activation of NF-κB (Ivashkiv, 1995; Warren and Berton, 1995). In the case of IL-4 
signaling, JAK1/3 is stimulated and activates STAT6 via phosphorylation. With NF-κB, 
STAT6 binds the DNA site upstream of the ε constant locus (Cε) and acts as a 
transcription factor. At this point activation-induced cytidine deaminase (AID) randomly 
converts cytosine bases to uracil, triggering repair enzymes to cleave the uracil 
nucleotides and fragment the DNA upstream of the Cε region. The process of uracil 
conversion and DNA fragmentation also occurs at the site of the actively transcribed 
constant regions of Cμ, and once both regions have breaks, the two ends are ligated 
together by DNA repair enzymes. The ligation process excises all other constant domains 
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between the Cε and the VDJ sequencing, which constitutes the rest of the antibody heavy 
chain. Once this process is completed, the activated B cells will now produce IgE 
antibodies.  
IgE has two aspects that make it crucial to establishing allergy as opposed to other 
antibody-mediated immunities. First is the cell types that possess IgE receptors. There are 
two types of IgE receptors, low-affinity FcεRII/CD23 and high-affinity FcεRI. CD23 
receptors are found on many hematopoietic cells, such as T cells, B cells, monocytes, and 
eosinophils. The FcεRI, on the other hand, is expressed by basophils and mast cells 
which, when activated, causes degranulation of these two cell types central to the allergic 
response (Stone et al., 2010). The second aspect of IgE is it is notoriously unstable when 
unbound, having a half-life of  ~2.5 days (Poulsen and Hummelshoj, 2007). However, it 
can be stabilized when attached to FcεRI on effector cells like mast cells, remaining for 
the cell lifetime (Stone et al., 2010). This process is called priming and allows for the 
immediate phase of the allergic response. 
Lymphocyte Differentiation 
 A crucial defining factor of Th2 immunity is the types of lymphocytes involved 
and their activation. The lymphocyte classification encompasses two distinct cell families 
that originate from a common lymphoid stem cell. The thymus-derived T cell and the 
bone marrow-derived B cells arise when lymphoid cells translocate to the thymus or 
continue to differentiation the bone marrow, respectively (Luckheeram et al., 2012).  
 B cells, as previously alluded to, are the body’s antibody-producing cells. During 
development in the bone marrow, pro-B cells restructure the genes of the heavy chain V, 
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D, and J regions and light chain V and J (Tonegawa, 1987). After restructuring, the pre-B 
cell receptor is formed and expressed by pre-B cells. The pre-B cells migrate to the 
spleen, where they further differentiate and become either marginal zone B cells or 
follicular B cells (Loder et al., 1999; Pillai et al., 2005). Once fully developed in this 
fashion, marginal zone B cells can become activated by an antigen, undergo antibody 
class switching, and form short-lived plasma cells releasing antibodies. On the other 
hand, follicular B cells may become either long-lived plasma cells or memory B cells 
(MacLennan, 1994; Liu and Arpin, 1997; Pieper et al., 2013). 
When immature T cells enter the thymus, they begin as double-positive (DP) cell 
that express CD4 and CD8 surface markers. CD4+CD8+ DP T cells go through a process 
of selection to become positive for either CD4 or CD8, and then migrate from the thymus 
cortex to the medulla. While in the medulla, T cells fully mature and can proliferate, 
naïve CD4+ or CD8+ T cell then move to a secondary lymphoid organ and wait to be 
activated (Luckheeram et al., 2012; Hogquist et al., 2015; Kurd and Robey, 2016; Kumar 
et al., 2018). CD8+ T cells engage in cytotoxic action against viral infected cells, while 
CD4+ or helper T cells release cytokines to promote differentiation, survival, and cell 
death of other immune cells depending on circumstances. 
CD4+ helper T cells function as the body's professional cytokine-producing cells 
that can further specialize into different subtypes: Th1, Th2, Tfh, and regulator T cells 
(Tregs). Th1 cells are intracellular pathogen combating T cells that are induced by the 
cytokine IL-12, IL-2, and interferon γ (IFNγ). Th1 cells, in turn, release the cytokines 
IFNγ, IL-2, and tumor necrosis factor α (TNFα) and promote lymphocyte proliferation. 
IFNγ released from Th1 cells, however, can inhibit Th2 activation (Berger, 2000; 
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Raphael et al., 2015). Th2 cells are important for defense against multi-cellular parasites 
and response stimulated by allergy. This subtype is induced by IL-4 signaling and 
subsequently releases IL-4, -5, -9, -10, and -13; their cytokine profile promotes the 
actions of monocytes, eosinophils, and mast cells while suppressing Th1 cells and 
promoting their subtype (Berger, 2000; Raphael et al., 2015). Tfh cells, on the other hand, 
are central in the activation of B cells through affinity maturation in lymphoid follicles. 
Differentiation is primarily controlled by a transcription factor Bcl6; in addition, Bcl6 
aids in forming germinal centers. Bcl6 is believed to be induced by IL-6 and -21 (Nurieva 
et al., 2009; Crotty, 2014). Tfh cells reside in the T-B cell border and promote B cell 
survival and proliferation, as well as their somatic hypermutation. In antibody 
development, Tfh cells provide both the surface interaction with the B cell using CD40L 
and release cytokines IL-21 and IL-4, an essential signal to induce IgE production in B 
cells (Yusuf et al., 2010; Crotty, 2014). Lastly, Tregs are regulator T cells that suppress 
inflammation. Differentiation of CD4+ cells to Tregs is driven by TGF-β through the 
transcription factor Foxp3. The main cytokines produced by Tregs are TGF-β and IL-10; 
these cytokines both have suppressive effects on other T cell subtypes, mast cells, and 
antigen-presenting cells (APCs), further the anti-inflammatory response, and promote 
immune tolerance (de Waal Malefyt et al., 1991; Speiran et al., 2009; Workman et al., 
2009; Raphael et al., 2015). Th cells, particularly the described subtypes, are central to 
the establishment and systemic effect of allergy, the balance between Th1 and Th2 
activity, immunosuppression, and antibody production.
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Cytokine Production 
As previously alluded, Th cells are defined by their cytokine profiles. Th cells 
may function as the immune system’s professional cytokine producer, but many other 
immune cells also release cytokines when activated. Notable examples include 
macrophages and activated mast cells (Bopst et al., 1998; Aderem and Ulevitch, 2000; 
Theoharides et al., 2007; Stow et al., 2009). Cytokines have a diverse range of functions 
depending on the cells that are receiving the signals. For the purpose of this dissertation, 
the function of cytokines on the Th1 vs. Th2 axis, immune suppression, and development 
of food allergies are discussed below.  
 TNF is one of the best-characterized cytokines. Soluble TNF was first identified 
for its ability to induce cell death and inflammation via its receptor, TNFR1. Activation 
of TNFR1 can lead to caspase-8 inducing apoptosis via the recruitment of TNFR1-
associated death domain (TRADD) to its intracellular domain (Locksley et al., 2001) or 
necroptosis and inflammation via MLKL (Micheau and Tschopp, 2003; Sun et al., 2012; 
Kalliolias and Ivashkiv, 2016). TNFR2, in contrast, is commonly referred to as the anti-
inflammatory TNF pathway. TNFR2 acts through TRAF2, leading to activation of 
MAPKs, NFκB, and AKT, which lead to prosurvival and repair activity (Rao et al., 1995; 
Probert, 2015; Kalliolias and Ivashkiv, 2016). Although TNF is one of the principal 
cytokines released by Th1 cells (Raphael et al., 2015), it also produced by many other 
cell types such as macrophages, astrocytes, microglia, eosinophils, and mast cells 
(Bischoff et al., 1999; Parameswaran and Patial, 2010). Mast cell-derived TNF may play 
a role in the late stages of allergic inflammation and/or degranulation (van Overveld et 
al., 1991; Bischoff et al., 1999). 
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 IFNγ is a core product of Th1 cells. It not only promotes the differentiation of Th1 
cells but also serves as a central proinflammatory signal. IFNγ acts via a JAK1/2 
mechanism, phosphorylating STAT1 to induce its transcription factor activity. 
Macrophages are pushed to the M1 phenotype by IFNγ, which in turn are 
proinflammatory cells with increased phagocytic activity, antibacterial functions, and 
release large amounts of TNFα, IL-12, and IL-1β (Jouanguy et al., 1999; Sica and 
Mantovani, 2012). For T cells, IFNγ enforces the Th1 phenotype while inhibiting Th2 
and Th17 differentiation by blocking IL-4/STAT6 signaling and GATA3 expression 
(Naka et al., 2001; Yu et al., 2004; Shachar and Karin, 2013). Another critical function of 
the IFNγ for Th1 cells is class switching to the IgG2a isotype in B cells (Ivashkiv, 1995). 
IgG2a is believed to be important for defense against bacterial infection (Kuijpers et al., 
1992). 
 Granulocyte-macrophage colony-stimulated factor (GM-CSF), also called colony-
stimulating factor 2 (CSF2), is a growth factor known to stimulate both granulocyte and 
monocyte production. GM-CSF is produced in endothelial cells, macrophages, 
fibroblasts, and activated T cells of CD4 and CD8 lineages and Th1 and Th2 cells 
(Griffin et al., 1990). Interestingly, resting T cells do not express GM-CSF but begin to 
produce the factor following stimulation with IL-3 or GM-CSF by APCs. The functional 
signaling between T cells and APCs suggests a role in cell function and cellular active 
state maintenance. GM-CSF is also induced by pro-inflammatory cytokines IL-1, IL-6, 
and TNFα and, when overexpressed, leads to severe inflammation due to fibrosis, 
macrophage expansion, and eosinophilia (Xing et al., 1996; Shi et al., 2006). GM-CSF 
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signals through a JAK2/STAT5 and ERK coupled multimeric receptor (Dougan et al., 
2019; Hamilton, 2019). 
 Another Th1 factor, IL-2, is best characterized as a T cell proliferation promoting 
factor. IL-2 is known to promote certain classes of activated T cells, notably Th1 and Th2 
cytokine release, differentiation of memory T cells, and activity of CD8+ T cells while 
blocking Th17 and Tfh (Ross and Cantrell, 2018). IL-2 acts through a JAK1/3 coupled 
receptor that activates either STAT3 or STAT5 (Ivashkiv, 1995). Evidence supports that 
STAT5 may be the primary transcription factor of action as knockout studies have shown 
a loss of both Tregs and peripheral T cell’s ability to proliferate (Moriggl et al., 1999; 
Snow et al., 2003). 
 The main Th2 cytokine, IL-4, was briefly discussed earlier in the context of IgE 
production. IL-4 production is best characterized in Tfh and Th2 cells, but mast cells, 
basophils, and eosinophils are also known to release IL-4 (Xin et al., 2007). The principal 
function of IL-4, in addition to IgE class switching, is regulation of inflammatory cells. 
For example, it is known to lead macrophages to M2 activation (Stein et al., 1992), 
suppress Th1 differentiation (Szabo et al., 1997), and suppress TNFα expression (Hart et 
al., 1991). The regulation of the pro-inflammatory pathway is a result of IL-4’s main 
antiparasitic activity. Parasites are notoriously unaffected by typical pro-inflammatory 
factors or involved cells, a Th2-type response being more effective at expelling parasites 
during certain stages of their life cycle (Moreau and Chauvin, 2010). 
IL-5 is another Th2 cytokine primarily produced by Th2 cells and mast cells 
(Kouro and Takatsu, 2009). Similar to IL-4, IL-5 induces antibody production in B cells 
(Takatsu et al., 1980). IL-5 also is vital for terminal differentiation of eosinophils, 
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survival, and chemotaxis (Yamaguchi et al., 1988; Rothenberg and Hogan, 2006). The 
signaling pathway of IL-5 is propagated via JAK1/2-STAT1/5, Btk, and Ras/ERK 
mechanisms. The Btk signaling pathway is implicated in the B cell function and 
proliferation role of  IL-5 signaling, while the Ras pathway seems to carry much of the 
eosinophil functions (Pazdrak et al., 1995; Takatsu, 1998). 
IL-6 is best described as an acute and chronic phase response cytokine, often one 
of the first products released during tissue damage and infections (Tanaka et al., 2014). 
IL-6 has been linked with pro- and anti-inflammatory signaling; which includes 
regulating macrophage differentiation through macrophage colony-stimulating factor (M-
CSF, also called colony-stimulating factor 2 (CSF2)) (Chomarat et al., 2000), dendritic 
maturation inhibition (Park et al., 2004), and Th1 differentiation by IL-4 signaling and 
IFNγ inhibition (Diehl and Rincón, 2002; Dienz and Rincon, 2009), and IL-21 induction 
of IgG production in B cells (Yang et al., 2016). This diverse range of functions is 
achieved through broad expression by various cell types, including dendritic cells, 
macrophages, B cells, fibroblasts, epithelial cells, and astrocytes (Kamimura et al., 2003; 
Dienz and Rincon, 2009). IL-6 signals through a JAK1/2/Tyk2 coupled receptor 
activating transcription factors STAT1/3 (Ivashkiv, 1995; Dienz and Rincon, 2009). 
IL-10 is a Th2 cytokine produced by Tfh, macrophages, dendritic, and B cells in 
addition to the evident Th2 cells (Couper et al., 2008). IL-10’s anti-inflammatory 
function is mostly indirect, downregulating macrophage TNFα, IL-1, and IL-12 as a 
means of suppressing T cell and NK cell production of IFNγ (Moore et al., 1993; Li et 
al., 1999a). IL-10 also functions through a JAK1-STAT1/3/5 pathway and PKB signaling 
(Riley et al., 1999). 
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IL-12 is central to the Th1/Th2 axis, promoting Th1 differentiation while 
suppressing Th2. IL-12 drives Th1 differentiation through IFNγ while suppressing Il-4, 
inhibiting Th2 (Wills-Karp, 2001; O'Shea and Paul, 2002). IL-12 is produced by 
macrophages, neutrophils, B cells, and dendritic cells (Heufler et al., 1996) and functions 
via heterodimer receptors IL-12p35 or p40. The IL-12Rs are mainly found on NK cells 
and T cells and act through a JAK2/TYK2 mechanism stimulating STAT3/4 
phosphorylation (Desai et al., 1992; Watford et al., 2004; Ma et al., 2015; Zundler and 
Neurath, 2015).  
IL-13 is the final of the canonical Th2 factors and is produced by Th2 cells in 
addition to NK T cells, mast cells, basophils, and eosinophils (Rael and Lockey, 2011). 
The signaling of IL-13, as previously stated, is vital in generating IgE antibodies in B 
cells, but also mucus secretion in goblet cells, and airway hyperresponsiveness, and 
fibrosis (Munitz et al., 2008). Though having their unique functions Il-4 and IL-13 have a 
great deal of functional overlap, IL-13, as a result, can bind to IL-4R, initiating its 
STAT6 pathway (Bao and Reinhardt, 2015). 
Food-Allergy-Association Neuropsychiatric Disorders 
History of Clinical Observations 
Food allergies are often found comorbid with various neuropsychiatric and 
behavioral disorders. This connection has been established with clinical observations and 
case studies described as far back as 1916, meaning this link has been around nearly as 
long as our current understanding of allergies in general. A report by Hoobler in 1916 is 
the oldest record, which described children with allergy vaguely as "restless, fretful, and 
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sleepless" (Hoobler, 1916). In 1949, Davison described in detail a series of cases 
observed in his practice, "For a long time, it has been noted that symptoms of bizarre and 
unusual cerebral disturbances occur in allergic patients." Davison collected information 
on 428 patients with psychiatric conditions and allergies as potential "cerebral allergy" 
cases (Davison, 1949). A large number of the cerebral allergy patients had described 
themselves as "mean, sulky, irritable, unable to be pleased, crying without cause, 
worried, suicidal, jumpy, and indecisive," which now can easily be understood as 
affective disorders. More modern studies have also reported comorbidity of allergy with 
depression, anxiety, attention deficit hyperactivity, oppositional defiant, and autism 
spectrum disorders (Tryphonas and Trites, 1979; Patten and Williams, 2007; Garg and 
Silverberg, 2014; Shanahan et al., 2014; Ferro et al., 2016; Theoharides et al., 2016; 
Topal et al., 2016). The spectrum of conditions has clear overlap with the symptoms 
identified by Davison. In these studies, it was established that a connection exists but not 
whether food allergies cause or exacerbate underlying psychiatric conditions. 
Comorbidity of Cow's Milk Allergy and Behavioral Disorders 
Of the foods common for hypersensitivities, CMA is the second most common 
allergy, surpassed only by peanut allergy, afflicting approximately 20% of allergic 
individuals (Warren et al., 2013). Cow's milk proteins are classified into two groups: 
caseins and whey proteins. The major whey proteins are α-lactalbumin and β-
lactoglobulin (BLG), the latter being the most common allergen in milk. BLG is absent in 
human milk and is highly allergenic, perhaps due to its resistance to proteolysis (Schmidt 
et al., 1995; Sélo et al., 1999; Iametti et al., 2002; Malacarne et al., 2002; Bossios et al., 
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2011). BLG often remains in whole or partially digested peptides in the intestines, likely 
to stimulate an immune response when encountering immune cells (Schmidt et al., 1995). 
 Among the general allergic population, CMA individuals are more likely to be 
diagnosed with neuropsychiatric disorders. Children with milk allergy are at an increased 
risk of being diagnosed with attachment, oppositional defiant, attention deficit 
hyperactivity disorders (Shanahan et al., 2014; Ferro et al., 2016; Topal et al., 2016). 
Experimental mouse models have further validated these findings by sensitizing mice to 
milk proteins and examining their behavioral abnormalities (de Theije et al., 2014; 
Germundson et al., 2018). These clinical and pre-clinical observations support the role of 
CMA in behavior and mood disorders. However, it is necessary to investigate further the 
effect of CMA with a more robust behavioral study paradigm to identify a specific 
mechanism between the immune system and behavior. 
The Role of Diet and the Immune System in Brain Function  
and Behavior 
 There is an ample amount of evidence for the immune system's regulation of the 
brain and behavior. As often referred to as "sickness behavior," an individual’s social, 
physical, and eating behavior are known to be affected by infections (Miller, 1964; Hart, 
1988; Yirmiya et al., 1999; Dantzer et al., 2008). Sickness behavior is likely an 
evolutionarily conserved behavior mechanism that forces the sick individual to focus on 
specific needs or change actions to better recover from the illness. The commonly 
identified behaviors in this condition are appetite loss, depression, and fatigue, primarily 
modulated by the hypothalamus-pituitary-adrenal axis (Dantzer et al., 2008). Behavioral 
changes are a consequence of the body's normal response to infection. 
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 Potential mechanisms that allow the immune system to influence behavior include 
increased brain cytokine levels (Li et al., 2009), glial cell activation (Pardo et al., 2005; 
Vargas et al., 2005), and changes in amino acid and neurotransmitter concentrations.  
Experimental models and meta-analysis of depression have found comorbidity with 
inflammatory factors of both cytokines and cell-mediated activation (Maes, 2011; Liu et 
al., 2012). In general, immune conditions seem to be closely tied to the diagnosis of 
behavioral disorders such as anxiety and depression. Inflammation has been additionally 
implicated in various other behavioral conditions. Immune mediators and the likelihood 
for developing inflammatory disorders have been found in autism spectrum disorder 
patients (Vargas et al., 2005; Zimmerman et al., 2005; Li et al., 2009). 
 In addition to the direct disruption by the immune system, the other aspect of food 
allergy is the specific dietary element acting as the source of the sensitivity impacting the 
gut and behavior. It has often been reported that individuals with neuropsychiatric 
disorders have behavioral symptoms exacerbated by certain foods (Crayton, 1986). 
Compounds in food and dietary habits have routinely been linked with behavioral and 
emotional disorders (Khalid et al., 2016). There is also a case to be made about the 
impact diet and nutrition have on behavior, studies have shown that typical “western” 
diets showed a greater risk of psychiatric incidence (Akbaraly et al., 2009; Jacka et al., 
2010; Sánchez-Villegas et al., 2011; Ruusunen et al., 2014). These assessments 
compound with existing knowledge on inflammation’s role in behavior and mood, as 
diets high in fat and carbohydrates are pro-inflammatory (Smith, 1991; Liu et al., 2002; 
Chrysohoou et al., 2004). Western diets typically lack in critical nutrients found in 
abundance in eastern, modern, or traditional diets. Deficiencies in compounds such as 
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omega-3 fatty acids, vitamin B12, and minerals such as zinc have been linked with 
increased risk of depression in some cohort studies (Maes et al., 1994; Penninx et al., 
2000; Murakami et al., 2010; Oddy et al., 2011). The interconnectedness of diet, gut 
health, inflammation, and behavior paired with the increasing diagnosis rate of behavioral 
disorders, including those resistant to conventional therapies, suggests that a subset of 
psychiatric patients may have an underlying food allergy resulting in resistance to 
behavior modulatory drug therapies. 
Food Allergy as an Etiology and Therapeutic Target 
Growing evidence supports the causative role of food allergies in neuropsychiatric 
disorders. With an extensive history of clinicians finding comorbidity between food 
allergies and neuropsychiatric diagnosis and the known role of inflammation and diet 
causing behavioral abnormality, discovering an immune-to-CNS signaling mechanism 
warrants investigation. Knowing that food allergies are highly variable and subjected to 
multiple factors, there is likely a subpopulation of undiagnosed allergic individuals at risk 
of developing behavioral disorders. With this understanding, treatment with conventional 
neuropharmacological therapies would be ineffective. Exploring a mechanism by which 
peripheral food allergies, even in mild cases, can influence behavior is invaluable and 
provides a novel mechanism for treating and preventing neuropsychiatric disorders. To 
achieve this aim, aspects of the gut-brain axis (GBA) such as absorption of 
neurotransmitter precursors, the microbiome, and modes of peripheral to central signaling 
are likely therapeutic targets. 
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Mechanisms of Gut-Brain Communication 
An Overview of the Gut-Brain Axis 
The GBA is an increasingly investigated mode of communication within the 
body. The GBA encompasses a broad range of factors like diet, the microbiome, and gut 
inflammation which influence other organ systems. This GBA's core is the bidirectional 
communication between the central nervous system and enteric nervous system 
controlling processes like digestion and satiety. The GBA consists of the collection of 
neural, immune, and endocrine signaling pathways between the central, autonomic, and 
enteric nervous systems (Carabotti et al., 2015).  
Within the gut, precursors needed for nervous system function and other essential 
compounds not natively produced in our bodies, including those produced by bacteria, 
are absorbed and processed—the clearest example of this is serotonin/5-
hydroxytryptamine. Our gut contains 90% of the serotonin in the body, which is derived 
from tryptophan. Tryptophan is an essential amino acid, which our bodies cannot 
produce. Tryptophan is instead absorbed from our diet with the aid of our commensal 
microbiota. Once absorbed, tryptophan can be transported to the CNS and converted into 
serotonin by the enzyme tryptophan hydroxylase (Lillesaar, 2011; Hoglund et al., 2019). 
Under normal circumstances, this route is sufficient to supply the necessary precursors 
for the nervous system; however, alteration of the microbiota via sustained changes in 
diet, infection, or inflammatory diseases of the gut can disrupt normal function 
(Holtmann et al., 2017). Subsequently, dysfunction of gut tryptophan absorption and 
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serotonin synthesis reduction can lead to depression and various neuro-signaling 
disorders. 
Conversely, efferent signals from the brain to the gut are necessary for 
homeostatic function. Inverse to the system we have previously described, stress disrupts 
gut microbiota function. Experimental models have demonstrated that social stressors 
impact the microbiota (Galley et al., 2014; Carabotti et al., 2015). One possible 
mechanism of microbiota changes is the autonomic nervous system's control of secretory 
function within the gut, which can directly influence microbe populations in the intestine.  
The Role of Gut Microbiota in the Immune  
and Nervous System 
The microbiota has vast implications across many systems. Allergic inflammation 
is both a cause and effect of dysbiosis (Stefka et al., 2014; Hussain et al., 2019; Matsui et 
al., 2019). Food allergy as an inflammatory condition is capable of breaking down normal 
gut barrier function leading to changes in normal gut bacteria. Alternatively, gut bacteria 
act as regulators of the local immune system and, if dysregulated, make the host 
susceptible to food allergy. Both functions are potential mechanisms, and in addition, gut 
bacteria changes are commonly found in individuals with neuropsychiatric disorders, 
especially those paired with gut dysfunction. (Wang et al., 2011; Bunyavanich et al., 
2016; Cenit et al., 2017; Pulikkan et al., 2018; Savage et al., 2018). Both the loss of 
neuroactive compounds produced by gut bacteria and dysregulations of the local immune 
system can influence behavior and brain function. 
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Cytokines and Their Role in CNS Communication 
Cytokines are crucial to the mechanism of the gut-to-CNS signaling. As 
previously stated, cytokines are the primary way immune cells communicate with each 
other and non-immune cells. Many factors such as TNFα, IL-6, IFNγ, IL-4, and IL-10 
have well-characterized interactions with the CNS, including their roles in behavior 
modulation (Kronfol and Remick, 2000; Zorrilla et al., 2001; Anisman and Merali, 2003; 
Arosio et al., 2004; Shapshak et al., 2004; Theoharides et al., 2004; Li et al., 2009; 
Abbott et al., 2015). Though the exact mechanisms are not entirely characterized, glial 
cells such as astrocytes, oligodendrocytes, and microglia, are promising as they typically 
act as mediators between the CNS and immune cells (Eddleston and Mucke, 1993; John 
et al., 2003). There is currently evidence suggesting that allergy-induced inflammation 
releases cytokines that relay signals directly to the CNS via afferent sensory neurons or 
by stimulating resident immune cells in the brain like T cells and mast cells. 
Dissertation Research Objective 
This dissertation aims to further our laboratory’s objective to elucidate the 
mechanism(s) by which CMA can impact brain function and behavior. Our laboratory’s 
focus is the communication between the peripheral immune system and the CNS leading 
to behavioral abnormality. Our attention has focused on exploring the relationship 
between BLG allergy symptoms and T cell immune predisposition, glial cell function, 
blood-brain barrier integrity, and host-microbiome factors. The objective of this 
dissertation is to explore a mechanism of BLG-allergy, which leads to behavioral changes 
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through a cytokine-mediated peripheral to central signaling to glial cells. This dissertation 
is organized into three studies aimed at addressing the following questions: 
1. What is the behavioral and histopathological impact of BLG sensitization in a 
non-anaphylactic mouse model of CMA? 
2. Which brain signaling pathways and CNS mediators are differentially activated 
following BLG sensitization? 
3 Does genetic predisposition for a helper T cell bias influence the physiological 
and behavioral effects of CMA? 
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CHAPTER II  
METHODS  
Animals 
Three-week-old male and female C57BL/6J and BALB/cJ mice were purchased 
from Jackson Laboratories (Bar Harbor, ME, U.S.A.). On arrival, mice were caged by 
both sex and strain, and randomly divided into groups before housed under a 12-hr 
light/12-hr dark cycle in a specific-pathogen-free environment at the University of North 
Dakota animal facility. Mice were given ad libitum access to whey-free rodent diet 
(Teklad 2018, Envigo, Indianapolis, IN, U.S.A.) and ultra-filtered water. Body weights of 
mice were recorded weekly to assess health and growth throughout the experiment. All 
procedures involving mice were approved by the University of North Dakota Institutional 
Animal Care and Use Committee prior to experiments. 
Animal Use  
Sensitization  
Mice were randomly assigned to either sham or BLG-sensitization groups and 
given weekly intragastric oral gavage for 5 weeks (Figure 1). Sham and BLG treatment 
groups received vehicle solution with or without BLG. Vehicle solution contained 10 μg 
cholera toxin (CT; #100B, List Labs, Campbell, CA, U.S.A.) as an adjuvant in 200 μL 
sodium carbonate/bicarbonate buffer (0.2 M, pH 9.0), while the BLG solution contained 
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Figure 1.  Schematics of the experimental timelines in the studies. Starting at  
4-weeks of age, mice were given a weekly oral administration of 200 μL 
vehicle (carbonate/bicarbonate buffer containing 10 μg CT, pH 9.0) with 
or without 1 mg BLG for 5 weeks. (A) In study 1, during the 6th and 7th 
weeks, all mice were challenged with 50 mg BLG in 
carbonate/bicarbonate buffer (without CT), and their behavior was 
subsequently tested at 1- and 2-day post-challenge. One day after the last 
behavior test in Week 7, mice were sacrificed, and blood and tissue 
samples were harvested. (B) In study 2, During week 6, all mice were 
challenged with 50 mg BLG in sodium carbonate/bicarbonate buffer 
(without CT) and were sacrificed 1-day post-challenge. (C) in study 3, 
During week 6, all mice were challenged with 50 mg BLG in sodium 
carbonate/bicarbonate buffer (without CT), and their behavior was tested 
1-day post-challenge. 
29 
an addition of 1 mg BLG (#L0130, MilliporeSigma, St. Louis, MO, U.S.A.) in the 
vehicle. Two hours prior to and following treatment, normal whey-free diet was removed, 
and mice were fasted. 
Allergen Challenge  
Beginning on week 6 (1-2 days prior to behavioral testing), mice were challenged 
with BLG solution to assess for anaphylactic reaction. BLG solution contained 50 mg 
BLG in 200 μL sodium carbonate/bicarbonate buffer (0.2 M, pH 9.0) without the 
presence of adjuvant. Mice were fasted for 2 hrs before gavage and observed for 30 min 
following gavage to assess physical responses. 
Acute Physical Responses  
Following challenge, physical responses were assessed. Anaphylaxis symptoms 
were graded on a 0-5 point scale established in Li, et al. (1999)(Li et al., 1999b). Briefly, 
“0” on this scale indicates no reaction, “1” notes the presence of body scratching due to 
skin irritation, “2” indicates swelling, redness, and reduced activity, “3” denotes 
respiratory distress observed by labored breathing and cyanosis, “4” indicates shock 
symptoms by convulsion and lack of responsiveness, and a score of “5” is when death 
occurs following challenge (Table 1). Secondly, we assess allergy-induced hypothermia 
using a MicroTherma 2T Handheld Thermometer with a RET-3 probe (Braintree 
Scientific, Inc., Braintree, MA, U.S.A.). Mice were returned to their home cages and 
allowed to rest for one day until behavior tests.
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Table 1. Anaphylaxis scoring scales. Scores and symptom descriptions adapted from  
Li et al., 1999. (Li et al., 1999b) 
0 No reaction/clinical symptoms 
1 Scratching and rubbing around the nose and head 
2 Puffiness around the eyes and mouth, pilar erecti, reduced activity 
3 Wheezing, labored respiration and cyanosis around the mouth and tail 
4 No activity after prodding or tremor and convulsion 
5 Death 
 
Behavioral Testing  
Innate digging behavior was assessed by placing each mouse in an enclosure 
(24.8-cm width × 38.7-cm depth × 29.2-cm height) containing 5-cm thickness of clean 
corncob bedding. Mice were allowed to explore the enclosure freely for 20 min. The first 
5 min were used to acclimate mice to the enclosure, and the following 15 min were 
recorded for analysis of digging behavior. The frequency of digging activity was counted 
from the videos by two observers blinded to the mice's experimental conditions (Figure 
2A).  
Mice were individually placed in empty cages, and their grooming behavior was 
video-recorded for 10 min after 5 min of acclimation. As with the scoring of digging 
behavior, two blinded observers from the video recordings counted the grooming 
behavior frequency. The presence or absence of grooming activity was monitored by 
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giving 1 or 0 points, respectively, during each of 60 × 10-sec intervals. The sum of the 
points for the testing period (10 min) was considered the mouse's grooming frequency 
(Figure 2B).  
Tail suspension test (TST) was performed based on a previously described 
protocol. Briefly, mice were suspended by their tail from a horizontal bar with a piece of 
laboratory tape so that their nose was ~ 30 cm above the base of the bar support. The 
C57BL/6 strain is known to climb their tail; a plastic tubing piece was used to maintain 
the mice in the suspended position. Their attempts to escape from the position were 
during the 6 min video-recorded. The frequency and length of immobility and the latency 
to the first immobile episode were compared between groups as indications of 




Figure 2.  Behavior tests used in studies. During behavioral testing, which occurred 
1- or 2-days post-challenge, (A) digging and (B) grooming activity was 
recorded, and frequency during the testing period was quantified. (C) Tail 
suspension test for depression-like behavior was employed. (D) open field 
recordings were used to assess anxiety-like and mobility behavior. (E) The 
Elevated-zero maze was used to measure anxiety-like behavior. (F) 
Finally, cross maze was used to assess spatial memory behavior. 
 
Open field (OF) recordings were performed in a plexiglass enclosure  
(40.6-cm width × 40.6-cm depth × 38.1-cm height; San Diego Instruments, San Diego, 
CA, U.S.A.) with a defined 20-cm × 20-cm center zone was used (Figure 2D). Mice were 
individually placed in the same area of the enclosure outside of the center zone and 
allowed to freely explore for 10 min, and their spontaneous activities were recorded using 
an overhead digital video camera. The number of entries, total time spent, and average 
duration of visit to the center zone, and the number of fecal pellets produced during the 
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test duration, average speed, distance traveled, and time immobile were recorded to 
objectively assess anxiety-like behavior as well as overall activity levels using ANY-
maze software (Stoelting Co.). The number of fecal pellets was manually counted from 
the video recordings by two blinded observers as a mobility-independent measure of 
anxiety-like behavior (Figure 2D). 
Anxiety-like behavior was observed using an elevated zero maze (EZM; Stoelting 
Co., Wood Dale, IL, U.S.A.). Each mouse's activity on the EZM was recorded for 5 min 
(study 1) or 10 min (study 3). Mice were individually placed in one of the walled sections 
of the circular maze and allowed to explore freely. The time spent in the open zones, the 
number of entries into the open zones and the average duration of visit to the open zones 
were analyzed using ANY-maze software (Stoelting Co.) and manually validated by a 
blinded observer. A few mice failed to stay on the maze for the entire test duration, and 
they were excluded from the final analysis (Figure 2E). 
A cross maze was used to evaluate spatial working memory. The maze was 
custom-made with white plexiglass with four identical cross-shaped arms  
(5-cm width × 30-cm length) with a 5-cm × 5-cm center area and 15-cm high walls based 
on the specifications by Kulas, et al. (2018) (Kulas et al., 2018). Mice were individually 
placed in one of the arms designated as the starting arm and allowed to explore the maze 
freely for 12 min. The sequence of arm entries was recorded by an overhead digital video 
camera and analyzed by a blinded observer (Figure 2F). “Alternations” was defined as 
the instances where the mouse successfully entered all 4 arms of the maze without 
reentering a previously entered arm. The percentage of alternations was calculated using 
the following equation (Kulas et al., 2018): 
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% 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 = (# 𝑎𝑎𝑜𝑜 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑇𝑇𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 − 3⁄ ) × 100. 
All behavior testing was performed at the University of North Dakota Behavioral 
Research Core Facility. Apparatuses were thoroughly cleaned with Process NPD 
(STERIS, Mentor, OH, U.S.A.) between tests. On days with multiple tests mice were 
allowed to rest for at least 1 hr between tests. The ANY-maze software (Stoelting, Co.) 
was used to establish all test parameters, to control video recordings, and to compute the 
results. 
Sacrifice and Tissue Collection 
 Mice were euthanized via CO2 asphyxiation followed by intracardiac perfusion 
with phosphate-buffered saline (PBS; pH 7.4). Cardiac blood was collected prior to 
perfusion to prepare serum and plasma samples for immunoglobulin and cytokine 
ELISAs, respectively. For plasma samples, approximately 100 µL of blood was collected 
in EDTA-coated Microvette tubes (Sarstedt, Inc., Newton, NC, U.S.A.) and centrifuged 
for 10 min at 2,000 × g at 4°C. For serum preparation, blood was collected in microfuge 
tubes and allowed to coagulate for 30 min at room temperature before centrifuged at 
2,000 × g for 15 min at 4°C. Aliquoted serum and plasma samples were stored at −80°C 
until used. Brain was extracted and preserved for subsequent applications. Brains were 
separated into both hemispheres, the left hemisphere was preserved for histology, and the 
right was divided regionally, as depicted in Figure 3 for western blot analysis. In study 2, 




Figure 3.  Regional dissection of mouse brain for biochemical analysis. Diagrams 
depicting the dorsal (left), ventral (right), and sagittal (bottom) views of a 
mouse brain. Upon collection of brain samples, the left hemisphere  
(L, dotted outline) was immersion-fixed in 4% PFA while the right 
hemisphere (R, solid outline) was subdivided into the following five 
regions: Region 1, rostral brain including prefrontal and frontal cortices 
and underlying subcortical structures (e.g., striatum); Region 2, 
parietotemporal cortices and the hippocampus; Region 3, the thalamus and 





Enzyme-Linked Immunosorbent Assays (ELISA)  
In studies 1 and 2, the amount of antigen-specific IgE and IgG1 antibodies present 
in sera was quantified using ELISA. The wells of the ELISA plate were coated with 
20 μg/mL BLG in a 100 mM sodium carbonate/bicarbonate buffer overnight at 4°C, 
washed thoroughly, and blocked with PBS containing 0.05% Tween-20 and fetal bovine 
serum (Assay Buffer, eBioscience ELISA Support Pack Plus # BMS414, Thermo Fisher 
Scientific, Waltham, MA, U.S.A.). Sera isolated from the terminal blood of mice were 
diluted 1:1 for IgE or 1:50 for IgG1 detection with Assay Buffer before adding to the 
antigen-coated wells. The plate was incubated for 12 hrs at 4°C, and BLG-specific IgE 
was detected with biotinylated anti-mouse IgE (used at 1:1,000, #13-5992-81, 
ThermoFisher Scientific) or anti-mouse IgG1 (used at 1:1,000, #13-4015-82, 
ThermoFisher Scientific) followed by avidin-HRP and TMB (3,3′,5,5′-
tetramethylbenzidine) according to the manufacturer's instructions. The plate was read at 
450 nm on a Biotek ELx 800 microplate reader using Gen5 v3.02 software (Biotek 
Instruments, Winooski, VT, U.S.A.).  
In study 3, serum samples from mice were first diluted to 1:40 to adsorb IgG 
using magnetic protein G beads, and resulting supernatants were used for BLG-specific 
IgE detection. Bead-bound IgG was eluted in 50 mM glycine (pH 2.8) for 2 min at room 
temperature, neutralized with 1 M Tris buffer (pH 7.5), and used to detect BLG-specific 
IgG1 and IgG2a. Samples were placed in the allergen-coated wells and incubated 
overnight at 4°C. BLG-specific immunoglobulins were detected by respective anti-mouse 
secondary antibodies followed by avidin-HRP and using TMB as the substrate. Reactions 
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were terminated by adding 2 N H2SO4 prior to reading at 450 nm on a Biotek ELx 800 
microplate reader with Gen5 software (Biotek Instruments). 
The amount of TNFα in the midbrain samples was quantified using TNFα 
DuoSet® ELISA (#DY410, R&D Systems, Minneapolis, MN, U.S.A.) according to the 
manufacturer's protocol. Briefly, an ELISA plate (#2580, Corning EIA/RIA 8-Well 
Strips) was coated with TNFα capture antibody overnight at room temperature. After 
washing and blocking the wells, protein extract (200 ng/100 μL/well) was placed in 
duplicates and incubated for 2 hrs at room temperature. TNFα in the samples was 
visualized by sequentially incubating the wells with the detection antibody and 
streptavidin-HRP. The substrate reaction was allowed to occur for 20 min before 
termination, and the plate was read as described above. The mean of the duplicate values 
from each sample was taken, and TNFα concentration was calculated from the standard 
curve. 
Tissue Preparation for Histology  
The left hemisphere of the brain and the ileum were immersion fixed in 4% 
paraformaldehyde for 24 hrs. Following fixation, tissues were dehydrated in increasingly 
high sucrose-containing PBS solutions. First, immediately following fixation, tissues 
were places 15% sucrose for 24 hrs then placed in 30% for 24 hrs or until embedded. 
Fixed ileal tissues were placed in either optimal cutting temperature (OCT; study 2; 
#4583, Sakura Finetek, Torrance, CA, U.S.A.) solution or gelatin (study 1), and brain 
tissues were embedded in gelatin. Gelatin embedded ilea and brains were then processed 
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as explained in Nagamoto-Combs, et al. (2016) (Nagamoto-Combs et al., 2016) and 
frozen sectioned at 14 and 40 μm, respectively. 
Immunohistochemistry  
Tissue sections were treated with 0.3% peroxidase and blocked in PBS containing 
0.5% bovine serum albumin and 5% normal goat serum (#16210072, ThermoFisher 
Scientific) and incubated with a primary antibody against rabbit anti-mouse occludin 
(used at 1:100, #711500, ThermoFisher Scientific), glial fibrillary acidic protein (GFAP; 
used at 1:1,000, #12389S, Cell Signaling Technology, Boston, MA, U.S.A.), Iba1 (used 
at 1:1000, #019-19741, Wako Chemicals, Richmond, VA, U.S.A.), myelin basic protein 
(MBP; used at 1:500, #HPA049222, MilliporeSigma), or IgG (used at 1:500, #13-4013-
85, ThermoFisher Scientific) for 12–48 hrs at 4°C. Tissues were subsequently incubated 
in anti-rabbit IgG (used at 1:2,000, #PK-6101, Vector Laboratories, Burlingame, CA, 
U.S.A.) or mouse-adsorbed rabbit anti-rat IgG (used at 1:100, #BA-4001, Vector Labs) 
antibody. Immunoreactivity was visualized with Vector Elite ABC kit (#PK-6101, Vector 
Labs) with VIP as the chromogen (#SK-4600, Vector Labs). 
RNA Extraction and Reverse Transcriptase Quantitative PCR  
Ileal and brain tissue samples were homogenized in TRIzol solution (#15596018, 
Thermo Fisher Scientific) using 5-mm stainless steel beads in a Bullet Blender Storm 24 
(Next Advance, Troy, NY, U.S.A.) set to speed 6 for 3 min with 30-sec intervals. Total 
RNA was extracted and purified by ethanol precipitation according to the manufacturer's 
instructions. The amount of RNA was quantified using Nanodrop One (Thermo Fisher 
Scientific), and 1 μg of total RNA was used to synthesize cDNA with an iScript™ cDNA 
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Synthesis Kit (#1708891, Bio-Rad Laboratories, Hercules, CA, U.S.A.) by priming at 
25°C for 5 min, reverse transcription at 46°C for 20 min, and inactivation at 95°C for 1 
min. Quantitative PCR reactions were performed with 100 ng cDNA and specific primer 
sets for murine Tnfα (qMmuCED0004141, Bio-Rad), occludin (Ocln; fwd: 5′-
AAAGCAAGTTAAGGGATCTG-3′; Rev: 5′-TGGCATCTCTCTAAGGTTTC-3′, 
MilliporeSigma), phosphatidylserine decarboxylase pseudogene 1 (Pisd-ps1; fwd: 5′-
ACGAGTTTGCTGTCATGTGC-3′; Rev: 5′-TCAGTCATGTTCACCCCAAA-3′, 
MilliporeSigma), myocardial infarction associated transcript (Miat; fwd: 5′- 
CCCACATCTCTTTGCTTGAGTCC-3′; Rev: 5′- GCTCTTTGTGCCCAGCTCTTAAC-
3′, MilliporeSigma), maternally expressed 3 (Meg3; fwd: 5′- 
ACATGCTGGACCCAAGACTC-3′; Rev: 5′- CCTGAGCCCATTTCACAGAT-3′, 
MilliporeSigma), Heat shock protein h1 (Hsph1; fwd: 5′- 
CAGGTACAAACTGATGGTCAACA-3′; Rev: 5′- 
TGAGGTAAGTTCAGGTGAAGGG-3′, MilliporeSigma), Transferrin (Trf; fwd: 5′- 
TGGGGGTTGGGTGTACGAT-3′; Rev: 5′- AGCGTAGTAGTAGGTCTGTGG-3′, 
MilliporeSigma), RNA binding motif protein 3 (Rbm3; fwd: 5′- 
CTTCGTAGGAGGGCTCAACTT-3′; Rev: 5′- CTCCCGGTCCTTGACAACAAC-3′, 
MilliporeSigma), ribosomal protein S18 (Rps18; qMmuCED0045430, Bio-Rad) or 
glyceraldehyde 3-phosphate dehydrogenase (Gapdh; qMmuCED0027497, Bio-Rad) 
using iTaq™ Universal SYBR® Green Supermix (#1725120, Bio-Rad) on a C1000 
Touch Thermo Cycler (Bio-Rad) for 40 cycles (denaturing at 95°C for 15 sec, annealing 
at 60°C for 30 sec, and extension at 72°C for 30 sec). The resulting Cq values were 
calculated using Bio-Rad CFX Manager Software version 3.1. Target gene ΔΔCq values 
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were calculated by normalizing target Cq values to the Cq values of reference genes 
Rps18 or Gapdh in the brain and ileum, respectively. 
Western Blot Analysis  
Total proteins from each isolated region of the right brain hemisphere were 
extracted in RIPA buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1 mM Na3VO4 10 mM 
sodium fluoride, 1 mM EDTA, 1 mM EGTA, 0.2 mM phenylmethylsulfonyl fluoride, 
1% Triton X-100, 0.1% SDS, and 0.5% deoxycholate) and quantified using the Bradford 
method (Bradford, 1976). Western blotting was carried out with 25 μg of protein samples 
resolved on 15% SDS-polyacrylamide gels. Resolved proteins were transferred onto 
PVDF membranes and detected with a primary antibody against GFAP (used at 1:1,000, 
#12389S, Cell Signaling Technology), cyclooxygenase 2 (COX-2; used at 1:1,000, #sc-
1745, Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) or GAPDH (used at 1:1,000, 
sc-32233, Santa Cruz Biotechnology) overnight at 4°C or 2 hrs at room temperature with 
gentle rocking. The membranes were subsequently incubated in an appropriate HRP-
conjugated secondary antibody (Santa Cruz Biotechnology). Target proteins were 
visualized using Amersham ECL Prime Western Blotting Detection Reagent (#RPN2232, 
GE Healthcare, Pittsburgh, PA, U.S.A.) on an Aplegen Omega Lum G Gel 
Documentation System (Gel Company, Inc., San Francisco, CA, U.S.A.). After the 
detection of chemiluminescence signal, PVDF membranes were treated with 0.2 N 
sodium hydroxide for 10 min at room temperature with gentle agitation to remove the 
antibodies and re-probed for another target protein. The levels of proteins were 
quantitated from the captured image using LI-COR Image Studio Lite Software 5.0 (LI-
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COR Biosciences, Lincoln, NE, U.S.A.) and normalized to the amount of GAPDH 
detected from the same PVDF membrane. 
Gut Permeability Assay  
In study 2, mice were orally given 4 kDa fluorescein isothiocyanate (FITC) 
labeled dextran prior to sacrifice. The volume of FITC-dextran given was equal to 484 
μg/g mouse weight. Five hours following FITC-dextran gavage, the mice were sacrificed, 
blood was collected, and serum separated. Serum was placed on a 96-well plate, and 
FITC emission wavelength of 528 nm was read after excitation at 485 nm. The resulting 
emission was converted into a concentration of FITC based upon signal detected from 
standards. 
Cytokine ELISA Array  
Plasma samples prepared from terminal blood were used to profile cytokines and 
chemokines using Quantibody® Mouse Cytokine Array Q5 Kit. Samples were first 
diluted to 1:5 before assayed using the multiplex kit according to the manufacturer’s 
instructions. Upon completing the assay procedure, the slides were sent to RayBiotech 
Array Scanning and Analysis Services to quantify the fluorescence signals. The resulting 
fluorescence signal values were analyzed using RayBiotech Q-Analyzer®, an array-
specific Microsoft Excel-based software tool (https://www.raybiotech.com/files/analysis-
tools/QAM-CYT-5.xls).  
RNA-Sequencing and Ingenuity Pathway Analysis  
The quality and quantity of extracted brain RNA were assessed using Qubit 2.0 
Fluorometer and Agilent 2100 Bioanalyzer at UND Epigenetics Bioinformatics Core 
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Facility. Three highest-quality brain samples were chosen per treatment group and 
sequenced by Novogene Corporation (Chula Vista, CA, U.S.A) on an Illumina HiSeq X 
Ten sequencer (San Diego, CA, U.S.A.) with 150 bp paired-end reads. Bioinformatic 
analysis was performed by UND Epigenetics Bioinformatics Core Facility, identifying 
brain region-specific differentially expressed genes. 
 Pathway analysis was performed on regional differentially expressed genes using 
Ingenuity Pathway Analysis software (Qiagen Inc., Germantown, MD, U.S.A.). 
BLG/Sham Log2(fold expression) of differentially expressed genes (p-value < 0.05) were 
placed into analysis software and evaluated for brain-specific pathways to identify 
upstream regulators, canonical pathways, and disease states. 
Microbial DNA Extraction  
After 1 week of acclimation with the whey-free diet, each mouse was individually 
placed in a cage until stool samples were collected and returned to its home cage with 
original cage mates. Fecal pellets from each mouse were collected in an autoclaved 
microfuge tube using sterile forceps and placed on ice until pellets were harvested from 
all mice. Stool samples were frozen stored at −80°C until used for microbial DNA 
extraction. Additional fecal samples were collected in the same manner immediately prior 
to euthanasia to assess post-sensitization changes in fecal microbiomes. To compare fecal 
microbiome profiles, microbial DNA was extracted from stool samples using 
ZymoBIOMICS DNA kit (Zymo Research, Irvine, CA, U.S.A.)
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16s Sequencing and Microbial Pathway Analysis using Kyoto 
Encyclopedia of Genes and Genomes  
Extracted microbial DNA was sent to the Genome Technology Access Center at 
Washington University (St. Louis, MO, U.S.A.) for 16S ribosomal RNA gene 
sequencing. Sample library preparation for 8 hypervariable regions of the 16S gene was 
performed with Fluidigm Juno LP 192.24 IFC system. Sequencing was carried out on a 
HiSeq 3000 with approximately 11M 150 bp paired-end reads, yielding an average of 
44,277 reads per sample. The raw FASTQ files were assessed for quality by DADA2. 
The forward and reverse reads were truncated using filterAndTrim function of DADA2 
package at 140 and 130 base position, respectively. After dereplication by DADA2, 
filtered paired-end reads were merged, and a quality-aware correction model was used to 
remove noise and chimeras to call final amplicon sequence variants (ASVs) (Callahan et 
al., 2017). ASVs were classified taxonomically based on the SILVA database (version 
132, https://zenodo.org/record/1172783#.X3zfvy2ZOL8), and the ASVs that were not 
assigned to phyla or assigned to non-bacterial kingdoms by the phyloseq R package 
(version 1.32.0) (McMurdie and Holmes, 2013) were removed. Furthermore, the ASVs 
with prevalence < 9 and total abundance < 222 (lower quartile) were excluded from 
downstream analysis. Taxonomy classification for trimmed reads was performed by 
Kraken 2 (version 2.0.8-beta) (Wood et al., 2019) based on MiniKraken2_v1 database 
(version 201904). Differential species were screened out by the DESeq2 package  
(version 1.28.1).  
The alpha diversity metrics were analyzed using the estimate_richness function. 
Proportionally normalized data was used for Bray-Curtis Principal Coordinates Analysis 
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(PCoA) to reveal differences between experimental groups. The ‘Adonis’ feature from 
the vegan (version 2.5-6) R package was used to assess whether sample grouping by 
metadata factor accounted for inter-sample differences (Oksaren et al., 2020). The 
DESeq2 package (version 1.28.1) was used to identify significant differences in ASVs 
between groups (Love et al., 2014). Differential ASVs were then subjected to KEGG 
pathway profile analysis using Tax4Fun2 R package (version 1.1.5) (Wemheuer et al., 
2020) with ‘Ref99NR’ database mode and Tax4Fun2_ReferenceData_v1.1. KEGG 
pathways with adjusted p-value < 0.05 were considered significant after multiple testing 
correction. 
qPCR Quantification of Akkermansia muciniphila 
The abundance of A. muciniphila at pre- and post-sensitization was detected from 
100 ng of microbial DNA using quantitative PCR (qPCR). The species-specific primers, 
S-St-Muc-1129-a-a-20: 5’-CAG CAC GTG AAG GTG GGG AC-3’ and S-St-Muc-1437-
a-A-20: 5’- CCT TGC GGT TGG CTT CAG AT-3’ (Collado et al., 2007) and iTaqTM 
Universal SYBR® Green Supermix (Bio-Rad) were used to perform qPCR on a C1000 
Touch Thermocycler (Bio-Rad) for 40 cycles (denaturing at 95°C for 15 sec, annealing at 
55°C for 30 sec, and extension at 72°C for 30 sec). Cq values were computed using Bio-
Rad CFX Manager 3.1, and the amount of A. muciniphila was expressed as 2−Cq. 
Statistical Analysis  
All statistical analyses, except the microbiome analysis, were performed using 
GraphPad Prism 9 software (GraphPad Software, Inc., San Diego, CA, U.S.A.). 
Statistical significance of the differences between sham and BLG groups was 
45 
independently analyzed for male and female groups using unpaired t-tests. Welch's 
correction was used when sample sizes varied, and Mann-Whitney test was employed 
where normal distribution of data values was not observed. Differences between strain-
matched sham and BLG groups and between treatment-matched two strains were 
compared independently among male and female groups using two-way ANOVA with 
Fisher’s least significant difference (LSD) test, when multiple comparisons were 
necessary, unless specified in the figure legends. The ROUT method (Q=1%) was used to 
identify outliers in a group when appropriate, and the values were removed from the final 
results. A p value less than 0.05 (p < 0.05) was considered statistically significant.
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CHAPTER III  
RESULTS  
Study 1 – Astrogliosis Associated with Behavioral Abnormality in a 
Non-anaphylactic Mouse Model of Cow’s Milk Allergy  
Contents of this chapter were originally published in Frontiers in Cellular Neuroscience 
(Smith et al., 2019)  
Introduction 
Behavioral and emotional disorders, such as anxiety, depression, attention-deficit 
hyperactivity disorder (ADHD), obsessive-compulsive disorder, and autism, are major 
mental health problems that could severely affect quality of life. In the United States 
alone, ~20% of adolescents and adults are reported to have experienced mental disorders 
in 2016 (Center for Behavioral Health Statistics and Quality). The actual number of 
people who suffer from these conditions is expected to be greater than reported, 
considering that these disorders often go undiagnosed due to unwillingness of patients to 
disclose their conditions or failure of their caregivers to recognize the symptoms (Glazier 
et al., 2015; Hirschtritt et al., 2017; Klik et al., 2018). Even among diagnosed patients 
who seek treatments, some are resistant to conventional pharmacological and 
psychotherapeutic interventions, requiring increased dosage of medications and/or more 
aggressive treatments such as electroconvulsive therapy and neurostimulation (Al-Harbi, 
2012; Hirschtritt et al., 2017). Nonetheless, not all patients benefit from these treatments, 
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signifying the need for alternative intervention approaches for these debilitating 
conditions. 
Interestingly, certain dietary items have been long suspected to trigger or 
exacerbate emotional and behavioral symptoms (Crayton, 1986), suggesting a potential 
role of food allergy/hypersensitivity (FAH) in the etiology of neuropsychiatric 
conditions. While many clinical cohort studies have reported that significant behavioral 
comorbidities exist among individuals with FAH (Addolorato et al., 1998; Parker and 
Watkins, 2002; Costa-Pinto and Basso, 2012; Shanahan et al., 2014; Ferro et al., 2016), 
the contributory role of diet in neuropsychiatric disorders has been controversial due to 
insufficient pathophysiological evidence and inconsistent results across studies. In order 
to determine the causative role of FAH in behavioral changes without genetic, dietary, 
and environmental variables commonly associated with human cohorts, we utilized a 
mouse model of cow's milk allergy (CMA) and examined behavioral changes and 
pathophysiology in the gut and brain mediated by FAH. 
To observe CMA-mediated changes in typical innate activities of mice, a non-
anaphylactic mouse model of CMA was previously established by orally sensitizing the 
C57BL/6J strain of mice with a whey protein (WP) mixture and cholera toxin (CT) as an 
adjuvant (Germundson et al., 2018). These sensitized mice generally exhibited mild to no 
anaphylaxis upon WP challenge, allowing a series of behavioral assessments to be 
performed the next day. In this study, we limited the allergen to β-lactoglobulin (BLG; 
Bos d 5), in order to isolate the effect of this major whey allergen, which is absent in 
human breast milk (Malacarne et al., 2002). We report that BLG-sensitized male mice 
displayed anxiety- and depression-like behavior similar to the mice sensitized with the 
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WP mixture. Moreover, we found astrocytic hypertrophy in the ventral midbrain of the 
BLG-sensitized brain, particularly near the blood vessels, resembling the perivascular 
“barriers” or “cuffs” described in mouse models of experimental autoimmune 
encephalitis (EAE) (Voskuhl et al., 2009; Sofroniew and Vinters, 2010). These results 
indicated that oral BLG sensitization of otherwise healthy mice results in region-specific 
perivascular astrogliosis, likely modifying the functional property of the blood brain 
barrier. 
BLG Sensitization of C57BL/6J Mice Results in Increased Serum  
Levels of Allergen-specific IgE and IgG1 in Male Mice Without  
Eliciting Obvious Signs of Anaphylaxis After BLG Challenge 
To monitor the overall health and steady growth of the experimental mice, their 
body weights were recorded during the sensitization protocol. The average body weights 
of mice in each group before the initiation of sensitization (Week 1) and at the time of 
allergen challenges (Week 6 and 7) were compared between the sex-matched treatment 
groups (Figure 4A). No significant differences were found in the body weights between 
the groups at any of the time points examined, suggesting that BLG-sensitized mice had 
comparable growth to the sham mice. 
A week after the 5 weekly sensitization procedures, all mice underwent a BLG 
challenge in Week 6 for the assessment of their physical responses to allergen re-
exposure. No obvious signs of anaphylaxis were exhibited by male or female mice from 
both of the treatment groups at 30 min post-challenge. This lack of physical reactions to 




Figure 4.  Physical growth and adaptive immunity development during BLG 
sensitization. (A) Weights of mice were recorded during Weeks 1, 6, and 7 
of sensitization to assess potential impact of the sensitization regime on 
overall health and growth. (B, C) Serum isolated from the terminal blood 
was used to quantify the levels of BLG-specific IgE (B) or IgG1 (C) using 
ELISA. Values shown in the graphs indicate the group average ± SEM,  
*p < 0.05; ***p < 0.001. (Mann-Whitney test), male sham: n = 8;  




In order to ensure that the BLG-sensitization protocol successfully induced 
acquired immunity in our mouse model, we next determined the levels of serum BLG-
specific IgE and IgG1 using ELISA (Figure 4B, C, respectively). While the serum levels 
of BLG-specific IgE were comparable among the male and female sham groups, both of 
the BLG sensitized groups showed wider ranges of BLG-specific IgE levels. The serum 
samples from a few mice in each group contained much greater BLG-specific IgE than 
the others within the group (Figure 4B). There were modest but significant increases in 
the average levels of BLG-specific IgE in both sensitized male and female mice 
compared to their respective sham groups (male sham: 0.14 ± 0.04; male BLG: 0.5 ± 0.3; 
female sham: 0.10 ± 0.01; female BLG: 0.9 ± 0.5; n = 8 in all groups, p < 0.05, Mann-
Whitney test). When the extreme values were identified as outliers by GraphPad Prism 
software and removed from the analysis, the statistical significance of the BLG-induced 
IgE levels increased to p < 0.01 for male mice (male sham: 0.10 ± 0.02, n = 7; male BLG: 
0.23 ± 0.05, n = 7; one outlier from each group was removed from the analysis [sham, 
0.40; BLG, 2.37]). In contrast, removal of outliers from the female groups resulted in the 
loss of statistical significance for female groups [female sham: 0.10 ± 0.01, n = 8; female 
BLG: 0.17 ± 0.06, n = 6; two outliers removed from the analysis of the BLG group [3.58, 
2.32]. The analysis excluding the outliers is shown in Supplemental Figure 1. Similarly, 
BLG-specific IgG1 levels were also elevated in the sensitized mice for both sexes with 
less variability than IgE (Figure 4C). These results indicated that the BLG-sensitization 
procedure elicited acquired immunity toward BLG with elevated antigen-specific IgE and 
IgG1 in both male and female mice. Although a subset of sensitized mice showed greater 
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degrees of antibody productions, their apparent physical health was not visibly affected, 
and the allergen challenge did not result in anaphylaxis. 
BLG Sensitization Resulted in Anxiety- and Depression-Like  
Behavioral Changes in Male C57BL/6J Mice 
BLG-mediated changes in mouse behaviors were examined using 4 different 
behavioral tests. The digging behavior observation and EZM were performed after the 
first challenge while grooming behavior observation and TST were carried out after the 
second challenge (see the Methods section). The frequency of digging activity within the 
10-min observation period was 15 ± 3 in male sham, 21 ± 2 in male BLG-sensitized,  
13 ± 3 in female sham, and 16 ± 5 in female BLG-sensitized mice (n = 8 per group,  
Figure 5A). Although there was a trend toward increased digging activity in male BLG-
mice compared to their sex-matched sham, the difference did not reach a statistical 
significance (p = 0.1). However, the EZM showed a significant decrease in the average 
duration of visit to open zone in male mice (sham: 5.7 ± 0.6, n = 6; BLG: 4.1 ± 0.3;  
n = 7; p < 0.05) and not in female (sham 4.2 ± 0.3, n = 8; BLG: 4.6 ± 0.3; n = 7; 
Figure 5B). Further surveillance of the test recordings revealed that the mice with a 
shorter duration of visit to open zones often did not walk through the open zone to the 
other closed zone, but they briefly surveyed the entry to the open zone and returned to the 
original closed zone (See Supplemental Video 1 + 2). In addition, the analysis of 
grooming behavior after the second BLG challenge indicated that BLG-sensitized male 
mice groomed themselves more often than their sham counterpart (sham: 20 ± 3, n = 8;  
BLG: 41 ± 3; n = 8; p < 0.001) while no sensitization-dependent differences were 
observed between the female groups (sham: 36 ± 2, n = 8; BLG: 31 ± 4; n = 8), indicating 
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that only male BLG-sensitized mice displayed more anxiety-like behavior than sham 
mice (Figure 5C). Similarly with the TST (Figure 5D), only male BLG-mice exhibited 
more depression-like behavior than the sham with greater numbers of immobile episodes 
during the 6-min testing period (sham: 14 ± 3, n = 8; BLG: 24 ± 5; n = 8; p < 0.05) while 
female sensitized mice did not (sham: 20 ± 3, n = 8; BLG: 23 ± 3; n = 8). To assure that 
the observed behavioral differences in the sensitized mice were not due to lethargy-
related immobility, the total time in seconds mice were mobile during their digging tests 
were compared between the groups (Figure 5E). There were no obvious differences in the 
total time mobile among male and female sham and BLG mice, indicating that the 
changes in the behavioral parameters observed with the male BLG-sensitized mice did 
not result from physical or ambulatory difficulties. These results demonstrated that the 
male mice were susceptible to behavioral alterations upon BLG sensitization, even 
though they did not exhibit apparent anaphylactic reactions when challenged with the 
allergen.
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Figure 5.  Assessments of anxiety- or depression-like behavior after BLG challenge. 
Behavioral tests were performed at 1- and 2-day post-challenge.  
(A) Digging frequency was quantified by two observers who were 
unaware of the experimental conditions. Either the presence (1 point) or 
absence (0 points) of digging behavior was recorded in every 10-sec 
interval during the 10-min test period. The total points scored by the two 
observers were averaged and used as the final score for each mouse.  
(B) For EZM test, the average duration each mouse spent within the open 
zone per visit was computed by ANYmaze software and later validated by 
an observer. (C) Grooming frequency was quantified by two observers for 
scoring either the presence (1 point) or absence (0 points) of grooming 
behavior as described for the digging frequency scoring. (D) For TST, the 
number of immobility episodes was used as the measure of the mice's 
helpless behavior that reflected their depression-like state. (E) Total time 
mobile was also computed from the recordings during the digging 
behavior to verify their motility to distinguish their immobility from 
lethargy. Values shown in the bar graphs indicate the group average ± 





BLG Sensitization Altered the Levels of Tight Junction Protein  
and the Expression of Proinflammatory Cytokine in the  
Small Intestine 
Next, we sought to identify changes in different brain regions that might 
contribute to the observed sex-dependent behavioral abnormality. Since BLG-mediated 
behavioral changes were only observed in male mice, we focused our further analyses on 
male animals. Allergens that paracellularly enter intestinal mucosa through compromised 
epithelial tight junction barriers may be recognized as pathogens by antigen presenting 
cells (APCs) and initiate immune responses. To examine whether BLG sensitization 
resulted in decreased barrier integrity, the levels of a tight junction protein, occludin, 
were examined in the intestinal tissue. Immunohistochemical assessment of the ileum 
from the male sham (Figures 6A,a) and BLG-sensitized mice (Figures 6B,b) showed that 
there was decreased staining in the villi of the latter group. This decreased 
immunoreactivity for occludin was likely a result of post-translational regulation since 
the amount of occludin transcripts in the ileal tissue from BLG-sensitized mice did not 
differ from the sham mice when determined using RT-qPCR (Figure 6C). 
Aberrant paracellular infiltration of allergens could trigger inflammatory 
responses by intestinal immune cells. Thus, we also investigated the inflammatory status 
of the gut mucosa by determining the amount of a proinflammatory cytokine, TNFα. An 
RT-qPCR assay indicated that there was a modest but significant increase in TNFα 
mRNA in the ileum (Figure 6D), signifying the presence of proinflammatory events at 




Figure 6.  Immunohistochemical detection of occludin and the RT-qPCR assays for 
Ocln and Tnfα expression in the ileum of male sham and BLG mice . Ileal 
sections (14 μm) from male sham (A, a) and BLG (B, b) mice were 
immunostained for occludin. The red rectangles in panels (A, B) indicate 
where the respective higher magnification images, (a) and (b), were taken. 
The low-magnification (A, B) and high-magnification (a, b) images were 
taken with a 4X and 40X objectives, respectively. Scale bars: 500 μm for 
(A) and (B); 50 μm for (a) and (b). The expression levels of Ocln (C) and 
Tnfα (D) in the ileal tissue samples were also quantitated using RT-qPCR 
assay. The Cq values for Ocln and Tnfα were normalized to the Cq values 
of Gapdh (ΔCq) to calculate the expression values (ΔCq = 2−ΔCq). Values 
shown in the bar graphs are expressed as the fold change (ΔΔCq) ± SEM. 
*p < 0.05 (unpaired t-test with Welch's correction), n = 6–8.
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GFAP-Immunoreactive Astrocytes Were Hypertrophic in the Midbrain 
Region of the BLG-Sensitized Mice 
Under the hypothesis that glia cells could respond to inflammatory mediators 
from the intestine and elicit neuroinflammation that would ultimately result in altered 
behavior, brain tissues from sham and BLG-sensitized male mice were immunostained 
for astrocyte and microglia markers, GFAP and Iba1, respectively. Iba1-immunopositive 
cells were observed throughout the brain sections although we did not observe noticeable 
differences between sham and BLG-sensitized mice (not shown). GFAP-stained 
astrocytes were also found ubiquitously in the brain, but they were more localized to 
specific regions such as within the white matter. In midbrain sections, the majority of 
astrocytes were found within the substantia nigra pars reticulata (Figure 7).  GFAP-
positive cells were abundantly present in both sham (Figure 7A) and BLG-sensitized 
(Figure 7B) mice. Interestingly, astrocytes in this area of BLG-sensitized mouse brain 
appeared darker and their processes seemed greater in number and thickness  
(Figure 7b’, b”). Perivascular astrocytes were notably different, with apparently increased 
density of GFAP-positive end-feet contacting the vascular wall (arrowheads in  
Figure 7b’). These observations provided evidence for glial response, at least by 




Figure 7.  GFAP immunoreactivity in the midbrain of sham and BLG-sensitized 
mice. GFAP-positive astrocytes were identified by 
immunohistochemically staining brain sections (40 μm). Representative 
midbrain sections from sham (A, a', a”) and BLG-sensitized (B, b', b”) 
male mice are shown. The white rectangles in (A, B) indicate where the 
respective higher magnification images a'–b” were taken. The open 
arrowheads indicate dense GFAP-immunoreactive astrocyte end-feet 
along the blood vessel. The low-magnification (A, B) and high-
magnification (a'-b”) images taken with a 10X and 40X objectives, 




In order to verify our immunohistological observations, western blot analysis was 
performed using protein extracts from different brain regions (Figure 8, see Figure 3 for 
the division of the regions). The level of GFAP was slightly elevated in the Region 2 
(parietotemporal cortices and hippocampus) and Region 3 (thalamus and hypothalamus) 
of the BLG-sensitized mice, although the difference was not statistically significant 
(Region 2: 1.4 ± 0.2 fold, p = 0.1; Region 3: 1.5 ± 0.3 fold, p = 0.1). However, in Region 
4 containing the midbrain and rostral brainstem, the difference in GFAP levels between 
the two groups of mice was significant with a 1.6 ± 0.2 fold increase in the sensitized 
mice (p < 0.001). This result indicated that BLG sensitization resulted in upregulation of 
GFAP in this region, corroborating our immunohistological observation of hypertrophic 
astrocytes in the same region. As an additional marker of proinflammatory change, we 
next examined protein levels of COX-2 in the various brain regions (Figure 9). Exactly as 
observed when examining GFAP levels, a significant increase in COX-2 protein levels in 




Figure 8.  Western blot analysis of GFAP in the isolated five brain regions. Soluble 
proteins isolated from the 5 regions were resolved on discontinuous 15% 
SDS-polyacrylamide gels for western blot detection of GFAP (upper 
panels). (A) Region 1, (B) Region 2, (C) Region 3, (D) Region 4, and (E) 
Region 5 as described in Figure 3. Chemiluminescence signals for GFAP 
were digitally captured and shown in the upper panels. GAPDH was also 
detected from the same blots and used as a reference for loading 
variability (lower panels). The captured GFAP signals were quantified 
using LI-COR Image Studio Lite software and normalized to GAPDH 
signals. Values shown in the bar graphs indicate the group average ± 





Figure 9.  Western blot analysis of COX-2 in the isolated five brain regions. Soluble 
proteins isolated from the five regions were resolved on discontinuous 
15% SDS-polyacrylamide gels for western blot detection of COX-2 (upper 
panels). (A) Region 1, (B) Region 2, (C) Region 3, (D) Region 4, and  
(E) Region 5 as described in Figure 3. Chemiluminescence signals for 
COX-2 were digitally captured and shown in the upper panels. GAPDH 
was also detected from the same blots and used as a reference for loading 
variability (lower panels). The captured COX-2 signals were quantified 
using LI-COR Image Studio Lite software and normalized to GAPDH 
signals. Values shown in the bar graphs indicate the group average ± 





The Proinflammatory Cytokine, TNFα, Was Elevated in the  
Midbrain Region 
Based on our observation of astrogliosis and elevated COX-2 protein levels in the 
midbrain regions, we hypothesized that the GFAP-positive reactive astrocytes might be 
responding to and/or producing inflammatory mediator(s). Since astrocytes are capable of 
producing and responding to TNFα (Eddleston and Mucke, 1993), we measured the 
levels of this proinflammatory cytokine in the midbrain region (Region 4) using ELISA 
(Figure 10). As predicted, the amount of TNFα was significantly elevated in this region 
of BLG-sensitized mice by ~2.7-fold (sham: 1,273 ± 384 pg/mL; BLG: 3,469 ± 194 
pg/mL, n = 8). This result demonstrated that proinflammatory events are present at least 
in this region of the brain of BLG-sensitized mice and provided the evidence that 





Figure 10.  Quantification of TNFα levels in the midbrain region of sham and BLG 
male mice using ELISA. The levels of TNFα in the midbrain region were 
quantified by ELISA. Values indicate the group average ± SEM. ***p < 
0.001 (unpaired t-test), n = 8. 
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CHAPTER IV  
RESULTS  
Study 2 – Differential Myelination and Blood-Brain Barrier Associated 
Pathway Activation in Non-anaphylactic Model of Cow’s Milk Allergy  
Introduction 
 Food allergy is defined as a reproducible immune response to a specific food 
protein or allergen (Boyce et al., 2010). Classically food allergy is defined by an 
immediate IgE-dependent mechanism causing systemic anaphylaxis, respiratory distress, 
swelling, and hives (du Toit et al., 2010; Burks et al., 2012; Mousan and Kamat, 2016). 
However, for many years it has been shown that food allergies are comorbid with various 
behavioral disorders. Children with food allergies are more likely to be diagnosed with 
ADHD, anxiety, depression, and autism (Tryphonas and Trites, 1979; Patten and 
Williams, 2007; Yaghmaie et al., 2013; Garg and Silverberg, 2014; Shanahan et al., 
2014; Zerbo et al., 2015; Ferro et al., 2016; Topal et al., 2016). Despite the behavioral 
effects of food allergy being well characterized, an exact mechanism has yet to be 
elucidated.  
 One reason for the gap in understanding is likely due to the inherent variability in 
food allergies and symptom presentation (Hill and Hosking, 1995; Baehler et al., 1996; 
Rona et al., 2007; Dupont, 2014). For example, the allergic response can be broken up 
into the immediate IgE-dependent mast cell response and the late phase response.
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The late phase can last hours or days after the immediate phase is cleared and is 
underresearched (du Toit et al., 2010; Mousan and Kamat, 2016). For mast cells 
specifically, histamine release is commonly the primary focus of intervention; however, 
mast cells broadly and selectively release factors other than histamine, such as proteases, 
leukotrienes, and cytokines (Marshall, 2004; da Silva et al., 2014). The cytokine response 
is well known to amplify the proinflammatory reaction by stimulating many cell types 
and drive specific actions within the tissue.  There is abundant evidence of CNS-directed 
responses in both cytokines and mast cells potentially acting as the initiators of 
neuroinflammation and causing behavioral changes (Bradding, 1999; Zorrilla et al., 2001; 
Hofmann and Abraham, 2009; Li et al., 2009; Nautiyal et al., 2012; Abbott et al., 2015). 
 The risks of behavioral changes are not unique to overt allergic reactions, 
however. An additional point of variability in food allergies is that some patients are non-
anaphylactic and experience subclinical symptoms. These patients are less likely to be 
diagnosed or avoid their allergens, putting them at increased risk of repeated exposure. 
Combined, these factors highlight a subpopulation of patients who are sub-anaphylactic 
and are of increased risk for neuropsychiatric diagnosis. Therefore, due to their 
behavioral symptoms' atypical etiology, such patients are likely resistant to typical 
neuropharmacological intervention (Al-Harbi, 2012; Hirschtritt et al., 2017). To identify 
and treat these patients, it is necessary to improve diagnostic criteria and establish a 
mechanism by which peripheral allergy-induced inflammation can influence behavior. 
 To elucidate a potential mechanism, we sensitized C57BL/6J mice to the cow’s 
milk allergen β-lactoglobulin. We then compared sensitized mice to sham mice to 
characterize a clinical phenotype and neuropathology using RNA-sequencing and 
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immunohistochemistry. We report that transcriptional changes were found within the 
brain in a region-specific manner. These transcriptional changes were observed in the 
midbrain region previously identified as being impacted by food allergy (Germundson et 
al., 2018; Smith et al., 2019). The transcriptome changes implied increased blood vessel 
permeability and altered glial cell function within the midbrain. Increased blood vessel 
permeability caused by the blood-brain barrier's breakdown was further validated in 
BLG-sensitized mice using immunohistochemistry for serum proteins. These findings 
support disruption of normal barrier function being a critical step in the peripheral to 
central signaling mechanism for food allergy-induced psychiatric symptoms. 
Lack of Anaphylactic Symptoms in BLG-Sensitization of C57BL/6J 
Mice Despite Increased Serum Allergen-specific IgE 
A weekly recording of body weight was used to monitor the health of two groups 
of mice. Starting one week prior to the first week of sensitization until the week of 
sacrifice, the weights were recorded the day before administering vehicle or BLG 
containing solutions (Figure 1B, C). Mice set aside for transcriptomic analysis were 
sacrificed following challenge (Figure 1B), while mice set aside for anaphylactic scoring 
and histological analysis were sacrificed following testing (Figure 1C) (Week 6). 
Analysis of weight showed no difference in health between sham and BLG-treated mice 
based on comparable growth (Figure 11A). 
During the week 6 challenge, 30 min after gavage, observable anaphylactic symptoms 
were scored, and internal body temperature was recorded (Figure 11A and 11B, 
respectively). No difference in apparent anaphylaxis symptoms were observed in either 
group of mice, though 1 BLG mouse was observed to have reduced activity following 
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challenge (Figure 11B). Likewise, there were no significant temperature deviations 
present in either group of mice following challenge (Figure 11C). These data demonstrate 




Figure 11.  Clinical assessment of health and sensitivity of mice. (A) Body weight 
growth curve shows comparable weight gain throughout the process of 
sensitization between sham (open symbols) and BLG-sensitized (filled 
symbols) mice. (B) Symptoms were scored based on the symptom score 
table (Table 1). (C) Body temperature (°C) was measured 30 min after the 
allergen challenge. (D) BLG-specific IgE detected from terminal serum 
using ELISA. Fold change was calculated by normalizing optical density 
(OD) values obtained for BLG-sensitized (striped bars with filled 
diamonds) groups to sham groups (open bars with open triangles). Values 
shown in the graphs indicate the group average ± SEM, *p < 0.05 (Mann-
Whitney test), n = 4-5. 
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To ensure BLG-sensitivity was achieved, BLG-specific IgE was detected using 
ELISA (Figure 11D). Serum BLG-specific IgE was found to be elevated in sensitized 
mice despite a lack of anaphylactic symptoms. BLG-sensitized mice had increased fold-
OD compared to untreated sham mice (sham: 0.93 ± 0.11; BLG 3.95 ± 1.32; n = 5 in all 
groups, p < 0.05, Mann-Whitney test). Results indicate that BLG hypersensitivity was 
established in BLG-sensitized mice following the treatment regime. 
Plasma CCL24 and CXCL13 Significantly Increased Accompanied by 
Trended Increases in Other Th2 Cytokines 
Knowing that sensitization was achieved despite no apparent allergic symptoms, 
collected plasma was used to quantify circulating cytokines. Using multiplex ELISA, a 
panel of cytokines, chemokines, and associated immunological factors were quantified. 
BLG-sensitized mice had 2 chemokines significantly increased over sham mice  
(Figure 12). CCL24 (C-C motif chemokine ligand 24/eotaxin-2) a chemokine for 
eosinophils was increased approximately 5-fold in BLG mice (Figure 12F; Sham: 15.8 ± 
2.3 pg/mL; BLG: 79.2 ± 25.5 pg/mL; n = 5 in all groups, p < 0.01, Mann-Whitney test). 
CXCL13 (C-X-C motif chemokine ligand/B-lymphocyte chemoattractant) a chemokine 
for T and B-lymphocyte was increased 2.1-fold in BLG mice (Figure 12G; Sham: 86.0 ± 
13.2 pg/mL; BLG: 187.4 ± 31.5 pg/mL; n = 5 in all groups, p < 0.01, Mann-Whitney 
test). Though not significant, a trend for increase in IL-10 (Figure 12C) and IL-13  
(Figure 12D) was observed in BLG mice as previously reported in C57BL/6J mice 
(Smith et al., 2021). In addition to these previously identified factors, CXCL4  
(Figure 12H) and GM-CSF (Figure 12B) were also slightly increased in BLG mice, 
though not statistically significant. These analytes are suggestive of a Th2-type response 
71 
elevated in BLG-sensitized C57BL/6J mice. Many increased factors are routinely found 
elevated in allergic individuals or are central to the establishment of IgE-mediated 
hypersensitivity. These data provide further evidence that sensitization was achieved and 
suggest a role these analytes play in the systemic effects observed in our model system. 
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Figure 12.  Levels of immune mediators included in the Quantibody Mouse Cytokine 
Array 5 (QAM-CYT-5) were quantified from plasma samples. The 
abundances of (A) IL-6, (B) GM-CSF, (C) IL-10, (D) IL-13, (E) CCL5, 
(F) CCL24, (G) CXCL13, and (H) CXCL4 were quantified. Sham mice 
(open bars with open triangles); BLG mice (striped bars with filled 
diamonds). Bars indicate group average values ± SEM **p < 0.01 (Mann-
Whitney test), n = 5. 
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Impact of BLG-Sensitization on Gut Health and  
Intestinal Permeability 
 Previous results have eluded to changes in gut health resulting from non-
anaphylactic BLG allergy (Smith et al., 2019). RNA was extracted from the ileum, and 
the transcripts of proinflammatory cytokines Tnfα and IL-1β, Th2 promoting factor Il-4, 
and tight junction protein Ocln were quantified via RT-qPCR. The tested factors varied 
greatly within groups, likely causing none of the factors being significantly different.  
Il-1β was increased approximately 1.5-fold in BLG-sensitized mice, while Ocln was 
reduced to around 0.5-fold in BLG mice (Figure 13). Though not conclusive, these data 
coupled with previously identified occludin protein reduction (Smith et al., 2019) 
justified quantifying gut permeability.  
Mice were given FITC-dextran, and the amount that crossed the gut barrier was 
quantified from the serum. The exact amount of FITC fluorescence varied within groups 
(Figure 14). There were no differences between groups, both sham and BLG mice having 
0.24-0.26 μg/mL FITC-dextran in their serum. Based on these data, there appears to be 




Figure 13.  Ileum RT-qPCR fold change in transcription. Transcripts for Ocln, Tnfα, 
Il-1β, and Il-4 were quantified from ileum extracted RNA. Sham mice 
(open bars with open triangles); BLG mice (striped bars with filled 
diamonds). Bars indicate Cq values for Ocln and Tnfα were normalized to 
the Cq values of Gapdh (ΔCq) to calculate the expression values  
(ΔCq = 2−ΔCq). Values shown in the bar graphs are expressed as the fold 






Figure 14.  Serum FITC-dextran concentration. Mice were given 4 kDa FITC-dextran 
to assess the amount crossing the gut barrier. FITC fluorescence at an 
emission of 528 nm was recorded to detect abundance in serum. Sham 
mice (open bars with open triangles); BLG mice (striped bars with filled 
diamonds). Bars indicate group average values ± SEM (Mann-Whitney 




Regional Brain Transcriptional Changes Resulting from  
BLG-Sensitization 
 Brains extracted from mice set aside for transcriptomic analysis were divided 
regionally (Figure 3). RNA was extracted from region 1 (STR) containing the striatum 
and frontal cortex; region 2 (HPC) containing the hippocampus, temporal and parietal 
cortices; region 3 (THAL) containing the thalamus and hypothalamus; and region 4 
(MB), which contained the midbrain, and were sequenced. Fold change values of 
differentially expressed genes generated from RNA sequencing were used as input values 
for IPA. Upstream regulator activation states of regional transcriptome profiles were 
identified. A small set of regulators common across brain regions was identified from this 
analysis (Figure 15). Dio2 was found to have a negative z-score of activation in STR (z = 
-1.067), HPC (z = -2.360), and MB (z = -1.342) regions. Slc16a2, similarly, had negative 
z-scores across the STR (z = -1.000), HPC (z = -1.633), and MB (z = -0.577) regions. 
Psen1 had a negative z-score of activation in the STR (z = -0.269) and HPC (z = -0.269), 
while Eomes was positive in the STR (z = 1.000) and HPC (z = 1.000). Fmr1 was 
suppressed in the STR (z = -1.342) but active in the MB (z = 1.383). Notable Sox2 
signaling was also found highly suppressed in the MB region (z = -2.538).  
 With upstream regulators identified based upon the transcriptome profiles, we 
then organized regionally differentially expressed genes into canonical pathways and 
calculated an activation z-score (Figure 16). Within the STR a broad spectrum of 
pathways were differentially activated or suppressed. Notably, endocannabinoid 
developing neuron pathways (z = -1.414), endometrial cancer signaling (z = -1.000), IL-7 
signaling (z = -1.000), and B cell receptor signaling pathways (z = -0.707) were found to 
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have negative activation z-scores, while eNOS (z = 1.890), NFAT (z = 1.732), white 
adipose tissue browning (z = 1.732), Gαs (z = 1.414), nitric oxide (z = 1.414), 
synaptogenesis (z = 1.414), cAMP (z = 1.213), opioid (z = 0.943), Fcγ receptor mediated 
phagocytosis signaling pathways (z = 0.816) were activated. In the THAL the white 
adipose tissue browning pathway (z = -0.707) had a negative activation z-score while 
netrin (z = 1.890) and Th17 signaling (z = 2.000) was activated. However, in the MB 





Figure 15.  Ingenuity pathway analysis of regional upstream transcriptional regulators. 
A subset of statistically significant differentially activated upstream 
regulators were identified across multiple brain regions, including STR, 
HPC, THAL, MB (Figure 3). Heatmap color corresponds to activation  




Figure 16.  Ingenuity pathway analysis regional canonical pathway activation. 
Regional transcriptomes were analyzed in the IPA platform, and 
statistically significant differentially expressed genes (Based on p-value) 
were placed into canonical pathways based on database information. Log2 
fold change values (BLG/sham) were used as input values. From the 
number of differentially expressed genes within a pathway, the activation 
z-score was calculated. All displayed pathways were statistically 
significant *p < 0.05, n = 3. 
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We further performed disease state and cell function pathway analysis to assess 
the changes in cellular behavior and health of the brain resulting from peripheral allergy 
(Figure 17). In the STR, pathways involved in cell migration of brain cells/neurons (z = 
2.400), the quantity of dendritic spines (z = 1.732), synaptic transmission (z = 1.166), and 
the quantity of neurons (z = 0.928) were activated, while central nervous system 
development pathway (z = -0.970) was inactivated. Meanwhile, in the MB, inactivation 
of pathways associated with damage of the nervous system (z = -1.938), neuritogenesis (z 
= -0.865), and ischemic injury of the brain (z = -0.818) were observed. 
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Figure 17.  Ingenuity pathway analysis regional disease state pathway activity. 
Regional transcriptomes were analyzed in the IPA platform, and 
statistically significant differentially expressed genes (Based on p-value) 
were placed aligned with disease state and cell function pathways based 
on database information. Log2 fold change values (BLG/sham) were used 
as input values. From the number of differentially expressed genes within 
a pathway, the activation z-score was calculated. All displayed pathways 





Based upon previously observed differences in the MB, we focused on MB 
upstream regulators, canonical pathways, and anxiety behavior. A predictive pathway 
was constructed in IPA to investigate potential relationships between identified 
differentially expressed genes, predicted upstream regulators, disease states and canonical 
pathways of interest. Differentially expressed genes and the pathways for the 
proliferation and differentiation of glial cells, albumin permeability, the proliferation of 
oligodendrocyte precursors, anxiety, and emotional behavior were placed into a causal 
network. Based on the quantified differentially expressed genes and predicted activity 
states of the upstream regulators, these pathways' effects were predicted (Figure 18). The 
network predicted that increased permeability of albumin and anxiety behavior would 
occur, while glial/oligodendrocytes proliferation and differentiation and emotional 
behavior are decreased. These data are suggestive that glial cell function such as 
oligodendrocytes and astrocytes were inhibited, and capillaries are permeable to serum 
proteins compromising the blood-brain barrier. 
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Figure 18.  Midbrain causal network analysis. Upstream regulators within the 
midbrain and differentially expressed genes downstream of those 
regulators were placed into a network with using Qiagen IPA software 
based upon established connections within the database. The factors were 
placed in the network, and IPA generated an activation state for the 
pathways to evaluate the connection between differentially activated 
regulators, differentially expressed genes, and pathways of interest. 
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 To validate our sequencing results and factors central to the proposed mechanism 
between BLG-sensitization and behavioral changes. RT-qPCR was performed from the 
4 brain regions for Pisd-ps1, Miat, Meg3, Hsph1, Trf, Ccl11, Tnfα, and Ocln (Figure 19). 
The STR had reduced transcription on Hsph1 in BLG-sensitized mice  
(Sham: 1.000 ± 0.008, n = 3; BLG: 0.765 ± 0.034, n = 5; p < 0.01, t-test). Within the 
HPC region increased Meg3 (Sham: 1.000 ± 0.052, n = 4; BLG: 1.399 ± 0.093, n = 5;  
p < 0.01, t-test) and Tnfα (Sham: 1.000 ± 0.098, n = 4; BLG: 1.235 ± 0.057, n = 4;  
p < 0.05, t-test). No differences were observed in the THAL region for the validated 
genes, however in the MB, Miat (Sham: 1.000 ± 0.076, n = 4; BLG: 1.274 ± 0.281, n = 4; 
p < 0.01, t-test), Meg3 (Sham: 1.000 ± 0.070, n = 4; BLG: 1.236 ± 0.021, n = 4; p < 0.05, 
t-test), Trf (Sham: 1.000 ± 0.111, n = 4; BLG: 0.656 ± 0.034, n = 5; p < 0.05, t-test), and 
Ocln (Sham: 1.000 ± 0.074, n = 3; BLG: 0.692 ± 0.003, n = 3; p < 0.05, t-test) were 
differentially expressed. From these data it is clear that there is evidence for  
BLG-mediated blood vessel permeability and disrupted iron transport resulting from 
decreased Ocln and Trf, respectively. 
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Figure 19.  Validation of differentially expressed genes using RT-qPCR. The fold 
change of Pisd-ps1, Miat, Meg3, Hsph1, Trf, Ccl11, Tnfα, and Ocln were 
evaluated to validate RNAseq findings. Sham mice (open bars with open 
triangles); BLG mice (striped bars with filled diamonds). Bars indicate 
group The Cq values for Ocln and Tnfα were normalized to the Cq values 
of Gapdh (ΔCq) to calculate the expression values (ΔCq = 2−ΔCq). Values 
shown in the bar graphs are expressed as the fold change (ΔΔCq) ± SEM 




Increased Capillary IgG Permeability in Midbrain of  
BLG-Sensitized Mice 
 Based upon our findings at the RNA level, along with pathway analysis and 
previously observed astrogliosis (Smith et al., 2019), we focused on the immunoreactivity 
of myelin and blood-brain barrier integrity. The disruption of Trf and its role in 
oligodendrocyte development and function had great potential for impacting myelination 
in the brain. Myelination was investigated by staining for MBP. Despite the convincing 
loss of Trf transcription and pathway evidence for disruption of oligodendrocyte function, 
no evidence of differential MBP staining was observed (Figure 20). From these data, we 





Figure 20.  Immunoreactivity of MBP in retrosplenial cortex of sham and BLG 
sensitized mice. MBP-positive myelin and oligodendrocytes were 
identified by immunohistochemically staining brain sections (40 μm). 
Representative cortex sections from sham (A, a') and BLG-sensitized 
(B, b') male mice are shown. The red rectangles in (A, B) indicate where 
the respective higher magnification images a' and b’ were taken. The low-
magnification (A, B) and high-magnification (a'-b”) images taken with a 
2.5X and 20X objectives, respectively. Scale bars: 1 mm for (A) and (B); 
100 μm for a' and b’. Quantification of optical density was performed 
using QuPath. Sham mice (open bars with open triangles); BLG mice 
(striped bars with filled diamonds); bars indicate group average values ± 
SEM (Mann-Whitney test), n = 18-20.
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The reduction of Ocln gene expression in the midbrain region suggests a 
breakdown in the tight junctions necessary for capillary structure and the selectively 
permeable barrier between the circulation and the brain parenchyma. To assess the 
integrity of the blood-brain barrier, we performed immunohistochemistry for the IgG. 
IgG is abundant in the circulation but is occluded from nervous tissue. In sham mice, 
well-defined intact capillaries were observed with light surrounding background  
(Figure 21a’), while in BLG mice, hazy light capillaries are observed with a much darker 
background (Figure 21b’). The differential staining between the groups can be observed 
throughout the midbrain; here, we represented sections of the substantia nigra pars 
reticulata (a’+b’). We then quantified the optical density of the IgG stain within the 
totality of representative sections. Optical density was higher in BLG-sensitized mice 
(Sham: 0.111 ± 0.012, n = 7; BLG: 0.192 ± 0.013, n = 6; p < 0.001, t-test). We futher 
investigated other brain regions (Supplemental Figure 2), including the cerebellum, an 
area where no differential staining was observed. In addition, we observed blood vessels 
in cross-section where high amounts of IgG was deposited in BLG-sensitized mice. 
These observations demonstrated increased blood vessel permeability, which has allowed 




Figure 21.  Immunoreactivity of IgG in midbrain region of sham and BLG-sensitized 
mice. The OD of IgG quantified extravascular IgG within the brain 
parenchyma (40 μm). Representative midbrain sections from sham (A, a') 
and BLG-sensitized (B, b') male mice are shown. The red rectangles in 
(A, B) indicate where the respective higher magnification images a'-b” 
were taken. The low-magnification (A, B) and high-magnification (a', b’) 
images taken with a 2.5X and 40X objectives, respectively. Scale bars: 
1 mm for (A) and (B); 50 μm for a' and b’. Quantification of optical 
density was performed using QuPath. Sham mice (open bars with open 
triangles); BLG mice (striped bars with filled diamonds); bars indicate 
group average values ± SEM (Mann-Whitney test), ***p < 0.001, n = 6-7. 
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CHAPTER V  
RESULTS  
Study 3 – Anxiety-like Behavior and Intestinal Microbiota Changes as 
Strain- and Sex-dependent Sequelae of Mild Food Allergy in Mouse 
Models of Cow’s Milk Allergy  
Contents of this chapter were originally published in Brain Behavior and Immunity 
(Smith et al., 2021) 
Introduction 
Food allergy, defined as “an adverse health effect arising from a specific immune 
response that occurs reproducibly on exposure to a given food” (Boyce et al., 2010), is an 
increasingly prevalent health concern worldwide (Mullins, 2007; Liu et al., 2010; Gupta 
et al., 2018; Loh and Tang, 2018; Sicherer and Sampson, 2018). In the United States, 
where approximately 8-10% of children and adults are afflicted with food allergy, cow’s 
milk allergy (CMA) has been reported as the second most common food allergy in both 
age groups (Gupta et al., 2018; Gupta et al., 2019). Clinical presentations of CMA can 
vary across individuals, and their manifestations may be immediate or delayed (Hill and 
Hosking, 1995; Baehler et al., 1996; Koletzko et al., 2012; Dupont, 2014). Symptoms that 
are typically recognized as “allergic reactions” include edema, hives, diarrhea, vomiting, 
respiratory distress, and systemic anaphylaxis, which occur immediately after ingestion 
of milk via immunoglobulin E (IgE)-mediated responses (du Toit et al., 2010; Burks et 
al., 2012; Mousan and Kamat, 2016). Delayed symptoms of CMA are more generalized 
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cutaneous and gastrointestinal discomfort, such as eczema and constipation, and can 
emerge several hours to days following milk consumption via IgE-independent 
mechanisms (du Toit et al., 2010; Mousan and Kamat, 2016). 
In addition to the clinical presentations mentioned above, mood, cognitive, and 
behavioral symptoms have been associated with CMA, and thus, neuropsychiatric 
disorders such as anxiety, depression, attention deficit hyperactivity disorder (ADHD), 
and autism may partly be neurological manifestations of hypersensitivity to cow’s milk 
proteins and other dietary allergens in some individuals (Davison, 1949; Speer, 1954; 
Boris and Mandel, 1994; Hak et al., 2013; Lyall et al., 2015; Topal et al., 2016; Xu et al., 
2018). In support of this notion, removal of suspected food from patients’ diet has been 
reported to alleviate their symptoms while reintroduction exacerbates them (Davison, 
1949; Speer, 1954; Boris and Mandel, 1994; Stevens et al., 2010). Furthermore, oral 
immunotherapy of children with CMA was found to significantly improve anxiety 
(Carraro et al., 2012). Despite a large number of case reports and cohort studies that 
demonstrated positive correlations between neuropsychiatric conditions and atopic 
diseases (Afari et al., 2001; Heaney et al., 2005; Mostafa et al., 2008; Yaghmaie et al., 
2013; Garg and Silverberg, 2014; Lyall et al., 2015; Ferro et al., 2016; Goodwin et al., 
2017; Busquets et al., 2019; Blöndal et al., 2020), CMA or other food allergies as a 
pathophysiological trigger of mood and behavioral symptoms has not been fully 
acknowledged in the field, but rather perceived as a psychological trigger of fear arising 
from the anticipation for accidental exposures to offending allergens (Cummings et al., 
2010; Walkner et al., 2015; Herbert et al., 2016; Polloni and Muraro, 2020). Inconsistent 
results across clinical studies, perhaps due to multiple variables associated with the 
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cohorts, have also likely contributed as inconclusive evidence for the role of food allergy 
as a causal factor for neuropsychiatric symptoms. Indeed, variables, such as genetic 
background and ethnicity, diet, and medical history, are challenging to normalize with 
human subjects in addition to the differences in the presentations, number, and severity of 
food allergies. Furthermore, intestinal microbiota, which has been increasingly implicated 
in both allergy (Inoue et al., 2017; Kourosh et al., 2018; Hussain et al., 2019) and 
neuropsychiatric disorders (Finegold et al., 2002; Wang et al., 2013; Naseribafrouei et al., 
2014; Kelly et al., 2016; Gupta et al., 2019), is another possible variable that may affect 
study outcomes and should be taken into consideration. 
Mouse models, therefore, provide valuable tools by allowing researchers to 
control many of these variables. Previously, we and others demonstrated that allergic 
sensitization to cow’s milk proteins elicited behavioral abnormalities in otherwise healthy 
wild-type mice (de Theije et al., 2014; Germundson et al., 2018; Smith et al., 2019; 
Germundson et al., 2020). Moreover, these studies showed that the increases in c-Fos 
immunoreactivity (de Theije et al., 2014), degranulated mast cell numbers (Germundson 
et al., 2018), astrogliosis (Germundson et al., 2018; Smith et al., 2019), and 
proinflammatory cytokines (Smith et al., 2019) were found in the brains of allergen-
sensitized mice. These results suggested that behavioral symptoms in food allergy were 
more than comorbidity, prompting further investigation of CMA as a causative factor that 
could influence brain function and behavior. 
In our mouse model, CMA-associated behavioral changes were observed only in 
male mice and not in female mice (Germundson et al., 2018; Smith et al., 2019). 
Interestingly, sex differences have also been reported in humans for behavioral disorders 
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and food allergies (Altemus, 2006; Kelly and Gangur, 2009; Acker et al., 2017; Xu et al., 
2018; Murray et al., 2019). Together with individual differences in offending allergen 
types, symptom presentations, and reaction severity, the susceptibility toward CMA-
associated behavioral manifestations may depend on the genetic background of allergic 
individuals.  
In this study, we therefore examined the influence of strain and sex differences in 
CMA-induced behavioral manifestations using male and female mice of two genetically 
distinct strains, C57BL/6J and BALB/cJ. Mice were sensitized to β-lactoglobulin (BLG: 
Bos d 5), a major allergen in bovine whey, for 5 weeks and challenged with BLG during 
the 6th week to assess their immediate physical reactions. Anxiety-like behavior and 
spatial memory were also tested one day after the allergen challenge. In addition, fecal 
microbiomes were compared among the mouse groups to determine the potential 
contribution of sex and strain in influencing intestinal microbiota after BLG sensitization. 
Our results indicated that these genetic variables significantly affected CMA sequelae 
and their extent, including immediate reactions to the allergen, behavior changes, 
systemic cytokine levels, and intestinal microbiota. 
BLG Sensitization Produced Distinct Physical Responses in C57BL/6J 
and BALB/cJ Mouse Strains upon BLG Challenge 
During the 6 weeks of sensitization, body weights of mice were recorded weekly 
to monitor overall health. As observed in our previous study (Smith et al., 2019), BLG 
sensitization had no impact on the overall growth of sex-matched mice (Figure 22A). 
When challenged with 50 mg of BLG in Week 6, most of the C57BL/6J mice, regardless 
of sex, were asymptomatic (Figure 22B) and scored 0 on the anaphylaxis scale (Table 1). 
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A few mice in the BLG-sensitized group showed minor symptoms although the 
maximum score did not exceed 2, and the differences between the average scores of sex-
matched sham and BLG-sensitized groups were not statistically significant (male 
C57BL/6J sham: 0.10 ± 0.09, male C57BL/6J BLG: 0.6 ± 0.3, p = 0.10; female 
C57BL/6J sham: 0.10 ± 0.09, female C57BL/6J BLG 0.5 ± 0.2, p = 0.10; n = 10 in all 
groups). While the sensitized BALB/cJ mice of both sexes also did not score more than 2, 
many more animals presented with observable symptoms than sex-matched C57BL/6J 
mice, and the differences between the average scores of the sex-matched sham and BLG 
groups for BALB/cJ were significantly different (male sham: 0.10 ± 0.09, male BLG:  
1.2 ± 0.3, p = 0.0007; female sham: 0.10 ± 0.09, female BLG: 1.8 ± 0.2, p < 0.0001;  
n = 10 in all groups). Sex- and treatment-matched strain differences in clinical scores 
were only significant between BLG sensitized female sham and BLG mice (p < 0.0001). 
Similarly, when body temperatures were measured to assess allergen-induced 
hypothermia (Figure 22C), the majority of BLG-sensitized male and female C57BL/6J 
mice maintained their normal body temperature at 30 min post-challenge, showing no 
significant differences between sex-matched sham and BLG groups (male C57BL/6J 
sham: 37.9 ± 0.2; male C57BL/6J BLG: 37.5 ± 0.4; female C57BL/6J sham: 37.75 ± 
0.09; female C57BL/6J BLG: 37.3 ± 0.4; n = 10 in all groups). However, BLG-sensitized 
BALB/cJ groups of both sexes clearly presented allergen-induced hypothermia reflective 
of histaminergic action from mast cells (Makabe-Kobayashi et al., 2002) (male BALB/cJ 
sham: 38.6 ± 0.3, male BALB/cJ BLG: 36.8 ± 0.7, p = 0.006; female BALB/cJ sham: 
37.52 ± 0.06; female BALB/cJ BLG: 35.7 ± 0.5, p = 0.0007; n = 10 in all groups). In 
addition, as with the clinical scores, BLG sensitized female BALB/cJ group displayed 
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greater hypothermic responses than sex-matched C57BL/6J mice (p = 0.003). In contrast, 
the strain differences in allergen-induced hypothermia in BLG sensitized mice were not 
significant in males (p = 0.27). These results indicated that the severity of allergic 
responses was sex- and strain-dependent, with female BALB/cJ mice exhibiting most 
robust reactions among the BLG-sensitized groups tested, followed by male BALB/cJ 
mice. In contrast, BLG-sensitized C57BL/6J mice displayed minimally observable 





Figure 22.  Physical responses of mice to BLG sensitization and challenge. (A) Body 
weight charts depicting comparable growth of male and female sham 
(open symbols) and BLG-sensitized (filled symbols) C57BL/6J (triangles) 
and BALB/cJ (diamonds) mice measured weekly during the sensitization 
procedure. (B) Clinical symptoms observed by individual mice were 
determined at 30 min after BLG allergen challenge in Week 6. Symptoms 
were scored based on the symptom score table (Table 1). (C) Body 
temperature (°C) measured at 30 min after the allergen challenge. Male 
C57BL/6J (blue), male BALB/cJ (red); female C57BL/6J (green), female 
BALB/cJ (orange). Bars in B and C indicate group average values ± SEM 
(two-way ANOVA), **p < 0.01, ***p < 0.001, ****p < 0.0001, n = 10. 
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Allergen-specific Immunoglobulins were Differentially Produced in 
BLG-sensitized Mice in a Sex- and Strain-dependent Manner 
To validate the development of adaptive immunity after the sensitization 
procedure, subclasses of BLG-specific immunoglobulins, IgE, IgG1, and IgG2a, were 
individually detected using ELISA (Figure 23, also see Supplemental Figure 3). When 
compared to respective sham mice, BLG-specific IgE (Figure 23A) was significantly 
elevated approximately by 2-fold in the sera of sensitized male C57BL/6J mice (1.8 ± 0.4 
fold, n = 10, p = 0.05) and male and female BALB/cJ mice (male: 2.1 ± 0.4 fold, n = 10, 
p = 0.006; female: 2.20 ± 0.41 fold, n = 10, p = 0.0007), but not in BLG-sensitized 
female C57BL/6J mice (1.0 ± 0.2 fold, n = 10, p = 0.28). In contrast, neither male nor 
female C57BL/6J mice showed allergen-specific IgG1 production (Figure 23B) even 
though robust increases in serum levels of BLG-specific IgG1 was detected in the 
sensitized BALB/cJ mice of both sexes (male: 46 ± 3 fold, n = 10, p < 0.0001; female 
BALB/cJ BLG: 43 ± 3 fold, n = 10, p < 0.0001). Similarly, elevated levels of BLG-
specific IgG2a were found in both male and female BALB/cJ mice (male: 8 ± 5 fold,  
n = 10, p = 0.04; female: 10 ± 3 fold, n = 10, p < 0.0001) but not in C57BL/6J mice  
(Figure 23C). These results indicated that BALB/cJ mice responded to BLG sensitization 
by productions of all immunoglobulin subclasses tested. In contrast, such response was 
limited to allergen-specific IgE in male C57BL/6J mice whereas females of this strain did 
not show significant immune responses after the 5-week sensitization regimen and an 
allergen challenge. Thus, the sex and strain of mice influenced the extent and the class of 




Figure 23.  Serum levels of BLG-specific immunoglobulin isotypes. Terminal blood 
samples were used to detect BLG-specific serum IgE (A), IgG1 (B) and 
IgG2a (C) using ELISA. Fold change was calculated by normalizing 
optical density (OD) values obtained for BLG-sensitized groups to those 
for sex- and strain-matched sham groups. Sham mice (open bars with open 
triangles); BLG mice (striped bars with filled diamonds); male C57BL/6J 
(blue); male BALB/cJ (red); female C57BL/6J (green); female BALB/cJ 
(orange). Bars indicate group average values in fold changes ± SEM  
(two-way ANOVA), *p < 0.05, ****p < 0.0001, n = 10. 
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Anxiety-like Behavior Differentially Manifested in BLG-sensitized Male 
C57BL/6J and BALB/cJ Mice after Allergen Challenge without 
Affecting General Activity and Cognitive Function 
For the OF test, we first tracked the frequency of visits to the center zone, the total 
time spent in the center zone, and the average duration of each visit to the center zone at 
1-min intervals to detect possible time-dependent changes in anxiety-like behavior during 
the course of the 10-min testing period (Supplemental Figure 4). From this preliminary 
analysis, we observed that significant differences between the sham and BLG groups in 
the measured parameters were often apparent during the first 4 min as previously 
reported by others (Bailey et al., 2007; Tanda et al., 2009; Maeta et al., 2018) but became 
less evident during the latter half of the test duration. Thus, the activity parameters during 
the first 4 min of the test period were compared among the groups (Figure 24). BLG-
sensitized male C57BL/6J mice made significantly fewer entries to the center zone of the 
OF arena (sham: 6.8 ± 0.8, n = 8; BLG: 4 ± 1, n = 8, p = 0.001), spent less total time in 
the center zone (sham: 16 ± 5 sec, n = 8; BLG: 5 ± 2 sec, n = 8, p = 0.004), and spent less 
time in the center zone per entry (sham: 3 ± 1 sec, n = 8; male C57BL/6J BLG: 1.0 ± 0.3 
sec, n = 8, p = 0.03) than their sham counterparts (Figure 24A-C). The CMA-associated 
effects on these parameters were not statistically significant for male BALB/cJ mice and 
female mice of both strains. However, in comparison to C57BL/6J mice, all groups of 
BALB/cJ mice noticeably avoided the center zone during the test period, posing a 
challenge in detecting any changes with BLG sensitization. In an attempt to detect 
differences in anxiety-like behavior between the treatment groups for BALB/cJ mice 
using another approach, the numbers of fecal pellets produced during the test were 
counted (Crumeyrolle-Arias et al., 2014; Seibenhener and Wooten, 2015). Greater 
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numbers of fecal pellets, considered to reflect an increased anxiety-like state in rodents, 
were produced by BLG-sensitized male BALB/cJ mice than their sham control mice 
(Figure 24D, sham: 3.8 ± 0.5, n = 10; BLG: 6.1 ± 0.8, n = 10, p = 0.01) although no 
differences were found in any other groups.  
To differentiate anxiety-like behavior from motor deficits, we also examined 
general locomotor activities of mice, the total distance traveled, and total time immobile. 
There were significant inter-strain differences between sex- and treatment-matched 
groups, with BALB/cJ mice, regardless of sex or treatment, being overall less active than 
C57BL/6J and avoiding the center zone (Supplemental Figure 5). Furthermore, BLG-
sensitized male BALB/cJ mice traveled less distance than strain-matched sham mice, 
although the difference in time immobile was not statistically significant. In contrast, 
there were no significant differences between sex-matched C57BL/6J sham and BLG 
groups, suggesting that decreases in the number of entries to the center and time spent in 
the center observed in male mice of this strain were not likely due to reduced mobility.
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Figure 24.  Open-field activity monitoring test. Overall activity of mice in an open 
field arena was monitored one day after BLG challenge. The first 4 min of 
the test were analyzed to assess differences in the number of entries to the 
center area (A), total time spent in the center (B), and the duration of each 
entry to the center (C). In addition, the number of fecal pellets excreted 
during the test were counted as an alternative measure of anxiety-like 
behavior (D). Sham mice (open bars with open triangles); BLG mice 
(striped bars with filled diamonds); male C57BL/6J (blue); male BALB/cJ 
(red); female C57BL/6J (green); female BALB/cJ (orange). Bars indicate 
group average values ± SEM (two-way ANOVA), *p < 0.05, **p < 0.01, 




Anxiety-like behavior of mice was also assessed using the EZM test by 
monitoring their avoidance of the open zones (Figure 25). As observed with the OF test, 
the BALB/cJ strain exhibited overall greater tendency to avoid open zones of the EZM 
compared to sex- and treatment matched C57BL/6J mice. When comparing sex- and 
strain-matched groups, BLG-sensitized male mice of both strains made fewer entries to 
the open zones than their respective sham counterparts (Fig 25A; male C57BL/6J sham: 
16 ± 2, n = 8; male C57BL/6J BLG: 9 ± 2, n = 8, p = 0.01; male BALB/cJ sham: 6 ± 2,  
n = 10; male BALB/cJ BLG: 0.6 ± 0.3, n = 10, p = 0.03). Similarly, BLG-sensitized male 
C57BL/6J and BALB/cJ mice spent less time in the open zone than sex- and strain-
matched sham mice (Fig 25B; male C57BL/6J sham: 82 ± 9, n = 8; male C57BL/6J BLG: 
42 ± 12, n = 8, p = 0.006; male BALB/cJ sham: 26 ± 11, n = 10; male BALB/cJ BLG: 0.9 
± 0.4, n = 10, p = 0.05). In addition, sensitized BALB/cJ male mice also spent less time 
in the open zone per entry than sham mice (Fig 25C; male BALB/cJ sham: 2.5 ± 0.8,  
n = 10; male BALB/cJ BLG: 0.7 ± 0.4, n = 10, p = 0.03). No differences were found in 
female mice of either strain in these parameters. These results further supported that sex 




Figure 25.  Elevated zero maze test. Anxiety-like behavior of mice was observed on 
an EZM apparatus one day after BLG challenge. The number of entries to 
the open zones (A), total time spent in the open zones (B), and the 
duration of each entry to the open zones (C) were quantified. Sham mice 
(open bars with open triangles); BLG mice (striped bars with filled 
diamonds); male C57BL/6J (blue); male BALB/cJ (red); female C57BL/6J 
(green); female BALB/cJ (orange). Bars indicate group average values ± 
SEM (two-way ANOVA), *p < 0.05, **p < 0.01, ***p < 0.001,  
****p < 0.0001, n = 7-10. 
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To evaluate whether CMA altered cognitive function, spatial memory was tested 
by quantifying the number of spontaneous alternations performed in the cross-maze test. 
In contrast to anxiety-like behavior, the ability of mice to strategically explore each arm 
of the maze was not affected by BLG sensitization in either strain or sex (Figure 26A). 
However, it is important to note that many of the female BALB/cJ mice (5 sham and 6 
BLG mice) either stayed in the entry arm or did not complete a cycle into all arms during 
their test period (Fig 26B) and were therefore excluded from the final analysis of % 
alternations (Figure 26A). These results suggested that BLG sensitization did not affect 
cognitive ability with respect to spatial memory. No obvious strain differences were 




Figure 26.  Cross maze test. Spatial memory of mice was tested using a cross maze 
one day after BLG challenge. Mice were allowed to explore the maze 
freely for 12 min, and the numbers of successful sequence alternations 
(A) and total number of entries into the arms (B) were recorded manually 
from video files. The number of successful alternations of arm entries 
made by each mouse was converted to percent alternations using the 
equation described in the Materials and Methods section. Mice that did not 
leave the starting position were removed from the final analysis. Sham 
mice (open bars with open triangles); BLG mice (striped bars with filled 
diamonds); male C57BL/6J (blue); male BALB/cJ (red); female C57BL/6J 
(green); female BALB/cJ (orange). Bars indicate group average values ± 
SEM (two-way ANOVA), **p < 0.01, ****p < 0.0001, n = 5-10. 
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BLG Sensitization Yielded Distinct Sex- and Strain-dependent  
Plasma Cytokine and Chemokine Profiles 
  Because CMA-induced immunoglobulin production and anxiety-like behavior 
manifestation were sex- and strain-dependent, it was likely that distinct immune 
responses with unique inflammatory mediators were triggered in each mouse group upon 
allergen challenge. Thus, we next characterized cytokines, chemokines, and associated 
immunologic factors in each experimental group. In particular, we expected to observe 
elevation of Th1- and Th2-associated cytokines in C57BL/6J and BALB/cJ strains as 
they reportedly have respective immune biases (Autenrieth et al., 1994; Nishimura et al., 
1997; Mills et al., 2000; Watanabe et al., 2004). To quantify the factors at the systemic 
level, we assessed the plasma samples using Quantibody® Mouse Cytokine Array Q5 
system (Figure 27, see Supplemental Figure 6 for the complete quantitative data). In 
BLG-sensitized male C57BL/6J mice, 9 analytes were significantly increased in 
comparison to their respective sham mice (Figure 27A). CCL1 (C-C motif chemokine 
ligand 1) and CSF1 (colony stimulating factor 1, also known as macrophage colony 
stimulating factor or M-CSF) showed the most striking changes with allergen 
sensitization by increasing 12 ± 4 fold and 9 ± 2 fold, respectively. However, the absolute 
amounts of these factors were relatively low (CCL1 in sham: 1.1 ± 0.5 pg/mL, BLG:  
13 ± 4 pg/mL; n = 10, p = 0.0003; CSF1 in sham: 19 ± 10 pg/mL, BLG: 176 ± 38 pg/mL; 
n = 10, p = 0.0001). Other analytes that were significantly induced in sensitized male 
C57BL/6J mice were, in the order of greatest to lowest, 7 ± 2 fold for IL-13  
(sham: 780 ± 261 pg/mL, BLG: 5353 ± 1667 pg/mL; n = 10, p = 0.0007), 6 422 ± 2 fold 
for CCL17 (sham: 83 ± 22 pg/mL, BLG: 528 ± 187 pg/mL; n = 10, p = 0.004), 4.5 ± 0.8 
423 fold for IL-21 (sham: 41 ± 23 pg/mL, BLG: 188 ± 33 pg/mL; n = 10, p = 0.0009),  
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4.0 ± 0.6 fold for FGF2 (Fibroblast growth factor 2;sham: 49 ± 11 pg/mL, BLG:  
195 ± 29 pg/mL; n = 10, p = 0.0001), 3.0 ± 0.7 fold for CCL12 (sham: 86 ± 35 pg/mL, 
BLG: 258 ± 57 pg/mL; n = 10, p = 0.02), 1.8 ± 0.3 fold for IL-10  
(sham: 177 ± 31 pg/mL, BLG: 318 ± 52 pg/mL; n = 10, p = 0.04), and 1.31 ± 0.05 fold 
for CCL9 (sham: 3762.313 ± 355 pg/mL, BLG: 4910 ± 191 pg/mL; n = 10, p = 0.002). 
None of the analytes quantified with this assay were induced in BLG-sensitized female 
C57BL/6J mice (see Supplemental Figure 6).  
The cytokine profile of BLG-sensitized male BALB/cJ mice was distinct from 
that of sex matched C57BL/6J mice, and 4 analytes were significantly reduced in BLG-
sensitized mice compared to the sham mice (Figure 27B). The analyte levels were lower 
by 0.5 ± 0.1 fold for IL-1β (sham: 103 ± 15 pg/mL, BLG: 56 ± 11 pg/mL, n = 10,  
p = 0.02), 0.5 ± 0.2 fold for IL-13 (sham: 414 ± 59 pg/mL, BLG: 216 ± 72 pg/mL;  
n = 10, p = 0.03) 0.3 ± 0.1 fold for CSF2 (sham: 157 ± 25 pg/mL, BLG: 49 ± 20 pg/mL,  
n = 10, p = 0.002), and 0.52 ± 0.05 fold for TNFRSF1A (sham: 1087 ± 121 pg/mL, BLG: 
566 ± 56 pg/mL; n = 10, p = 0.0002) in BLG sensitized mice. In contrast, 3 analytes were 
increased in BLG-sensitized female BALB/cJ mice (Figure 27C), including 2.6 ± 0.5 fold 
for IL-15 (sham: 683 ± 340 pg/mL, BLG: 1788 ± 353 pg/mL, n = 10, p = 0.007), 5 ± 2 
fold for TNFRSF1B (sham: 39 ± 8 pg/mL, BLG: 176 ± 61 pg/mL, n = 10, p = 0.02), and 
6 ± 2 fold for ICAM-1 (sham: 93 ± 40 pg/mL, BLG: 518 ± 184 pg/mL, n = 10, p = 0.02).  
This array data demonstrated that BLG sensitization resulted in altered levels of 
distinct sets of immunologic mediators in the circulation, with C57BL/6J male mice 
having the greatest number of mediators that were significantly affected. Therefore, our 
results indicated that the same allergen triggered varying immune responses depending 
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on the sex and strain of sensitized mice. Importantly, the cytokine profiles from BLG-
sensitized C57BL/6J and BALB/cJ mice failed to categorize their strain-specific 
responses simply into Th1 and Th2 responses, respectively. 
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Figure 27.  Plasma levels of immune mediators that were significantly different 
between sex- and strain matched sham and BLG-sensitized mice. Levels 
of the 40 immune mediators included in the Quantibody Mouse Cytokine 
Array 5 (QAM-CYT-5) were quantified from plasma samples. Only the 
analytes that showed significant differences between sex- and strain-
matched sham and BLG groups are shown for C57BL/6J male mice (A), 
BALB/cJ male mice (B), and BALB/cJ female mice (C). No significant 
differences in any of the detected analytes were observed in female 
C57BL/6J mice (not shown). The quantification of all analytes for all 
mouse groups are presented as Supplemental Figure 6. Sham mice (open 
bars with open triangles); BLG mice (striped bars with filled diamonds); 
male C57BL/6J (A); male BALB/cJ (B); female BALB/cJ (C). Bars 
indicate group average values ± SEM (Mann-Whitney), *p < 0.05, **p < 








BLG-sensitization Differentially Altered the Composition of  
Intestinal Microbial Community in a Sex- and Strain-specific Manner 
Because BLG was orally introduced during the sensitization procedure, we 
postulated that allergen sensitization and the subsequent challenge had produced 
inflammatory conditions in the intestinal tract and influenced the commensal microbial 
community. Altered intestinal microbiota has been implicated in a variety of pathological 
conditions, including food allergy and neuropsychiatric disorders (Wang et al., 2011; 
Scheperjans et al., 2015; Blazquez and Berin, 2017; Vuong et al., 2017; Pulikkan et al., 
2018). To assess whether BLG sensitization resulted in alterations in intestinal 
microbiota, we next performed microbiome analysis by 16S ribosomal RNA gene 
sequencing from stool samples. Following sequencing, microbial taxonomy was 
classified using amplicon sequence variants (ASVs) at the species level. Approximately 
400-500 species were classified in each treatment group (Figure 28A). There was a 
significant strain dependent difference in the number of observed species between 
C57BL/6J and BALB/cJ male sham mice (Figure 28A). Species richness was greater for 
BALB/cJ sham mice compared to respective C57BL/6J mice in males (C57BL/6J sham: 
392.2 ± 21.3, BALB/cJ sham: 500.3 ± 17.0; n = 10, p < 0.0001). Furthermore, assessment 
of alpha diversity indicated significant differences between sex- and strain-matched 
treatment groups for male C57BL/6J mice (Simpson index) and female BALB/cJ mice 
(Shannon and Simpson indices), showing BLG associated decrease and increase in 




Figure 28.  Effects of BLG sensitization on fecal microbiome. Microbial DNA was 
isolated from fecal pellets and 16S ribosomal RNA gene sequencing was 
performed. Fecal microbial compositions were determined as described in 
the Materials and Methods section, and alpha and beta diversities were 
assessed. (A) Assessment of alpha diversity with the number of observed 
species. Sham mice (open bars with open triangles); BLG mice (striped 
bars with filled diamonds). Bars indicate group average values ± SEM 
(two-way ANOVA), ****p < 0.0001, n = 10. (B, C) Assessment of beta 
diversity with Bray-Curtis principal coordinate analysis. Sham mice (open 
triangles); BLG mice (filled diamonds). Male C57BL/6J (blue); male 
BALB/cJ (red); female C57BL/6J (green); female BALB/cJ (orange).
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We next performed PCoA using the Bray-Curtis dissimilarity method to cluster 
the beta diversity of sex- and strain-matched treatment groups. There was clear separation 
between sham and BLG groups in both male and female C57BL/6J mice (Figure 28B). 
Similarly, the clustering of the two groups was distinct for female BALB/cJ mice, 
whereas some overlap was observed for male BALB/cJ mice (Figure 28C). These results 
suggested that intestinal microbial composition becomes altered with BLG sensitization, 
although the extent of the change may be strain-dependent. 
When taxonomic compositions from the experimental groups were compared at 
the phylum level, each group showed a distinct profile, although Firmicutes and 
Bacteroidetes were the two dominant bacterial phyla as reported elsewhere (Figure 29A). 
The relative abundance of these phyla was uniquely influenced by BLG sensitization in a 
sex- and strain-dependent manner (Figure 29B-I). For C57BL/6J, Verrucomicrobia and 
Proteobacteria were significantly lower in BLG-sensitized male mice, whereas 
sensitization resulted in a greater abundance of Bacteroidetes and Patescibacteria and 
reduced abundance of Actinobacteria in female mice. In contrast, for BALB/cJ mice, 
Cyanobacteria was the only phylum that was lower in BLG-sensitized male mice, while 
female mice did not show any significant differences between sham and BLG groups in 
the identified phyla. Among the differences described above, the most notable 
sensitization associated differences were reduced abundance of Verrucomicrobia in male 
C57BL/6J by 84.1% (0.16 ± 0.03 fold) and increased abundance of Bacteroidetes in 
female C57BL/6J by 30.5% (1.31 ± 0.07 fold).  The complete microbiome profiles for all 
the experimental groups are provided in Supplemental Figure 9. 
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Figure 29.  Sensitization-associated differences in the relative abundance of major 
bacterial phyla detected from fecal microbiome analysis. Microbial DNA 
was isolated from fecal pellets and 16S ribosomal RNA gene sequencing 
was performed. (A) Relative abundances of detected bacterial phyla were 
compared among sex-matched groups. (B-I) Relative abundance of each 
of the major phyla was compared to their sex-matched groups. Sham mice 
(open bars with open triangles); BLG mice (striped bars with filled 
diamonds); male C57BL/6J (blue); male BALB/cJ (red); female C57BL/6J 
(green) female BALB/cJ (orange). Bars indicate group average values ± 
SEM (two-way ANOVA), *p < 0.05, **p < 0.01, ***p < 0.001,  









Proliferation of Akkermansia muciniphila in C57BL/6J Male Mice  
was Inhibited with BLG Sensitization 
Because C57BL/6J male mice exhibited significant changes in intestinal 
microbiota associated with anxiety-like behavior, we focused on this group to investigate 
the potential role of their commensal bacteria in their behavioral and immunologic 
responses. Here, we examined the pre- and post-sensitization fecal amounts of 
Akkermansia muciniphila, a species belonging to the phylum, Verrucomicrobia, which 
was significantly decreased in BLG-sensitized mice (Figure 29E). A. muciniphila has also 
been implicated in various disease conditions, including neurological disorders (Wang et 
al., 2011; Hill-Burns et al., 2017; Li et al., 2019; Xu et al., 2019). As shown in Figure 30, 
the relative amounts of A. muciniphila detected in pre-sensitization samples from the 
sham and BLG groups were comparable, ranging from 4.5×10-7 to 1.1×10-5 (sham 
average: 4×10-6 ± 1×10-6 , BLG average: 3.2×10-6 ± 0.7×10-6 ; expressed as 2-Cq values). 
However, A. muciniphila increased in sham mice during the course of the 5-week 
sensitization period, averaging 22 ± 8 fold increases at post-sensitization with a range of 
2.2 to 5-fold increases. On the other hand, all BLG-sensitized mice, except one mouse 
identified as an outlier (2-Cq value: 9.4×10-6, see the Materials and Methods section), 
showed profound decreases in the relative amount of the bacteria after sensitization, 
averaging 0.2 ± 0.1 fold, indicating that the growth of this bacteria was stifled in this 
group. Because A. muciniphila was the predominant species of Verrucomicrobia 
identified and detected in the microbiome (Supplemental Figure 9), the significant 
reduction of the phylum observed in BLG-sensitized C57BL/6J male mice is therefore 




Figure 30. Differences in the amount of A. muciniphila in sham and BLG-sensitized 
male C57BL/6J mice before and after the sensitization procedure. 
Microbial DNA samples were isolated from fecal pellets that had been 
collected before (pre-sensitization) and after (post-sensitization) the  
5-week sensitization procedure. The amount of A. muciniphila in each of 
the DNA samples were quantified by qPCR using a specific primer pair. 
Sham mice (open bars with open triangles); BLG mice (striped bars with 
filled diamonds). Bars indicate group averages of individual  
2-Cq values ± SEM, **p < 0.01, ****p < 0.0001, n = 10., sham vs. BLG: 
two-way ANOVA; treatment-matched pre- vs post-sensitization values 
were compared using paired t-test. *p=0.01 indicates comparison between 
pre- and post-sensitization BLG. 
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The Altered Microbiome Profile of BLG-sensitized Male C57BL/6J  
was Associated with Molecular Interactions Known to Affect  
Neurological Functions 
In order to explore possible molecular targets that might have been influenced in 
our BLG sensitized mice, we identified the pathways that were associated with the 
microbial changes observed in this study using the Kyoto Encyclopedia of Genes and 
Genomes (KEGG) Pathway Database (https://www.genome.jp/kegg/pathway.html). 
Known molecular interaction pathways with significant differences between sex- and 
strain-matched sham and BLG-sensitized groups are presented as Supplemental Figure 8. 
We found a greater number of pathways that were significantly associated with the 
microbiome of BLG-sensitized C57BL/6J male mice than any other groups. Interestingly, 
among them were some pathways involved in neurological disorders and 
neurotransmission, such as serotonergic/dopaminergic synapses and Parkinson’s disease 
(Figure 31). Although the analysis does not articulate specific molecules within each 
pathway that were likely affected by the sensitization-associated microbiome changes in 
C57BL/6J male mice, the result suggests that the neurological functions were possibly 




Figure 31.  Central nervous system-related pathways associated with the changes in 
microbiota in BLG-sensitized mice. KEGG pathway analysis was used to 
identify known functional pathways that were significantly associated with 
the microbiome profiles in our mouse groups. Only the pathways that are 
related to the central nervous system functions are shown. All results from 
the KEGG pathway analysis are provided in Supplemental Figure 8. 
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CHAPTER VI  
DISCUSSION  
Study 1 – Astrogliosis Associated with Behavioral Abnormality in a 
Non-anaphylactic Mouse Model of Cow's Milk Allergy  
For several decades, the association of FAH with behavioral, emotional and 
cognitive impairments has been suggested, often referred to as “cerebral allergy” 
(Davison, 1949) or “allergic tension-fatigue syndrome” (Speer, 1954, 1958). More 
recently, a growing number of reports have more specifically described FAH 
comorbidities with depression (Patten and Williams, 2007; Garg and Silverberg, 2014; 
Ferro et al., 2016), anxiety (Lyons and Forde, 2004; Patten and Williams, 2007; Garg and 
Silverberg, 2014; Shanahan et al., 2014; Ferro et al., 2016), ADHD (Garg and Silverberg, 
2014; Shanahan et al., 2014; Ferro et al., 2016; Topal et al., 2016), and autism (Lyall et 
al., 2015; Xu et al., 2018). However, the evidence that FAH in fact modifies 
physiological functions of the brain is still insufficient, and the mechanism remains to be 
elucidated. 
One of the major obstacles in the assessment of brain pathophysiology in FAH-
associated neuropsychiatric conditions is controlling the variables associated with the 
study subjects, such as genetic background, diet, socioeconomic status, local 
environment, and culture, all of which may contribute to differences in behavior as well 
as FAH development. In addition, experimental parameters for quantitative assessments 
are often limited to evaluation scores on questionnaires for neuropsychiatric conditions
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and blood IgE levels and/or skin tests for FAH. While it is undeniably challenging to 
evaluate mood- and emotion-elicited behavior in animal models, performing a series of 
behavioral tests helps to validate the results. Furthermore, animal models provide many 
advantages in an experimental study by allowing to control genetic, environmental, and 
dietary variables and to directly evaluate pathophysiology of the brain and other organs. 
Indeed, a mouse model of CMA with the C3H/HeOuJ strain has been utilized to 
demonstrate autistic-like deficit in social behavior and neurochemical changes in the 
brain (de Theije et al., 2014). 
In the present study, we produced non-anaphylactic CMA in C57BL/6J mice 
using BLG as the allergen and assessed the cellular and molecular changes in the 
intestine and brain to identify CMA-induced pathology that might have contributed to 
their abnormal behavioral outcomes. During the 7 weeks of the sensitization/challenge 
period, both male and female mice showed no differences in their growth rate (Figure 
4A). Importantly, we did not observe overt anaphylaxis symptoms in any of the groups 
after each of the two challenges at Week 6 and 7, although significant increases in BLG-
specific IgE and IgG1 levels were observed in both male and female sensitized mice 
(Figures 4B, C). This result indicated that acquired immunity to BLG can be established 
without observable physical reactions. 
Our behavioral assessments of sham and BLG-sensitized mice included digging 
and grooming frequencies, EZM, and TST (Figure 5). Digging behavior in rodents is an 
innate burrowing behavior, and the test is often performed by placing the animal in a cage 
with a thick layer of bedding without or with marbles (Deacon, 2006). Unlike the WP-
sensitized mice we previously described (Germundson et al., 2018), BLG-sensitized mice 
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did not exhibit decreased digging behavior. Instead, there was an increased trend in male 
sensitized mice, suggesting that the behavioral effect of BLG sensitization appears to be 
distinct from that of the WP mixture. Although the reason for the discrepancy between 
the two mouse models of CMA in this behavioral outcome is not clear, it may be 
postulated that other constituents in the WP mixture, such as α-lactalbumin, 
immunoglobulins, and lactoferrin (Farrell et al., 2004), had a more diverse effect than 
BLG alone. 
Grooming is another intrinsic rodent behavior consisting of a complex series of 
movements, and the frequency, total time spent, and sequence of grooming can be 
affected by extrinsic factors such as stress (Kalueff et al., 2016). We observed that female 
sham mice groomed more frequently than their male counterpart (Figure 5C), and the 
frequency of female grooming behavior was not affected by BLG sensitization. On the 
contrary, BLG-sensitized male mice showed significantly elevated grooming behavior, 
indicative of their stressed or anxious state (Kalueff et al., 2016). This observation was 
corroborated by their performance in the EZM test, in which male BLG-sensitized mice 
spent significantly less time than the sham mice in the open zones when entered  
(Figure 5B). These results together support the notion that BLG-sensitized male mice 
exhibited anxiety-like behavior. 
Because anxiety and depression are often comorbid (Johansson et al., 2013; Tiller, 
2013), we also examined whether the BLG-sensitized mice would exhibit depression-like 
behavior. In the TST, depression-like behavior is quantified by the animal's immobility, 
which reflects decreased attempts to escape from the helpless position (Cryan et al., 
2005). Our results demonstrated that male BLG-sensitized mice indeed displayed 
130 
depression-like behavior, although no difference was observed between sham and BLG-
sensitized female mice (Figure 5D). From our observation that the overall activity of 
male and female mice did not differ between sham and BLG-sensitized groups, it is 
unlikely that the immobility resulted from inability to move or lethargy (Figure 5E). 
Taken together, our behavioral tests indicated that BLG sensitization elicited anxiety- and 
depression-like behavior in male-specific manner. This sex-dependent behavior 
manifestation was also observed with WP-sensitized mice and have been discussed 
previously (Germundson et al., 2018). 
Interestingly, similar sex differences in behavioral observations have been 
reported with human patients with neuropsychiatric disorders, including ADHD, 
obsessive-compulsive disorder (OCD), and autism spectrum disorder (ASD). Several 
meta-analysis studies have indeed found greater prevalence in male population (Hanna, 
1995; Gaub and Carlson, 1997; Gershon, 2002; Mathis et al., 2011; Russell et al., 2011). 
This male dominance in these conditions seem to arise from the fact that male patients 
exhibit more noticeable behavioral phenotypes than female patients. For example, boys 
with ADHD display more externalized and/or disruptive behavior than girls, who in 
contrast tend to show more internalized, inattentive behavior (Gaub and Carlson, 1997; 
Gershon, 2002). Similarly, some studies on sexual dimorphism in ASD symptomatology 
reported that boys have more severe autistic traits and therefore are more likely to be 
diagnosed with ASD than girls (Russell et al., 2011; Mandy et al., 2012). Biological 
factors, such as sex hormone-dependent structural development of the prefrontal and 
orbitofrontal cortices, thalamus, and basal ganglia (Maia et al., 2008), the volume of the 
pituitary gland (MacMaster et al., 2006), and polymorphisms in the serotonergic system 
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(Mathis et al., 2011; Verma et al., 2014; Shuffrey et al., 2017), have been suggested to 
underlie the sex differences in behavioral manifestations. 
In addition to behavioral differences, sexual dimorphism of the immune systems 
has been well-recognized. Gene regulation by gonadal hormones and the expression of 
X-chromosome genes are known to differentially affect the immune system in males and 
females, including immunoglobulin productions, T-lymphocyte functions and 
allergic/atopic disease susceptibility and symptom severity [see reviews by (DunnGalvin 
et al., 2006; Pennell et al., 2012; Klein and Flanagan, 2016)]. However, male dominance 
of food allergy appears to be inconsistent across studies, depending on allergen types and 
patient age groups, as well as on the study method used and year examined (Jarvis and 
Burney, 1998; Becklake and Kauffmann, 1999; Kelly and Gangur, 2009; Acker et al., 
2017). Therefore, the roles of these biological and immune dimorphisms in the sex-
specific behavioral response to BLG sensitization and challenge are complex and require 
further scrutiny in humans as well as in our animal models of CMA. 
Moving forward, we focused our pathophysiological investigation on male mice 
to assess histological and biochemical changes that might reflect the behavioral changes 
that deviated from the sham control. In orally-sensitized mice, the site of allergen insult is 
the gastrointestinal (GI) tract. Decreased mucosal occludin immunoreactivity and 
increased proinflammatory cytokine expression in the BLG-sensitized ileum suggested 
that the immune responses to the allergen during sensitization had impaired intestinal 
barrier (Figure 6). In addition, it is possible that dysbiosis had occurred during the 
sensitization and elicited these changes in intestinal physiology, since gut microbe 
compositions can be influenced by diet and shifts in compositions can result in 
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inflammation (Round and Mazmanian, 2009; Clements and Carding, 2018). These 
changes in the gut physiology and microbiota are likely to be produced gradually during 
the sensitization period, rather than immediately after the BLG challenge, since immune 
activation status in food-allergen sensitized mice has been reported to be heightened as 
evidenced by greater proliferative capacity of splenocytes compared to naïve mice 
without restimulation with the allergen (Li et al., 2000). However, time course of 
pathophysiology development and potential involvement of gut microbiota are yet to be 
determined in our mouse model. Loss of intestinal barrier and intestinal dysbiosis have 
been reported in autistic patients (de Magistris et al., 2010; Fiorentino et al., 2016) and 
their implication in pathogenesis of neuropsychiatric conditions has been reviewed in 
recent literature (Karakula-Juchnowicz et al., 2016; Grochowska et al., 2018). 
Inflammatory responses were also found in the brain of BLG-sensitized mice. 
Although we did not detect apparent microgliosis by Iba1 immunostaining (not shown), 
we observed notable differences in GFAP-positive astrocyte morphology in certain areas 
of the brain, especially perivascular regions of the midbrain (Figure 7). Interestingly, 
similar observations of hypertrophic perivascular astrocytes have been observed in our 
WP-sensitized aged mice (Germundson et al., 2018) and also reported in the spinal cord 
of EAE mice (Voskuhl et al., 2009). These astrocytes resemble scar forming astrocytes 
often described in central nervous system injuries and are thought to establish barriers to 
control infiltration of leukocytes from the blood circulation (Voskuhl et al., 2009; 
Sofroniew and Vinters, 2010). Importantly, increased expression of GFAP plays a crucial 
role in this barrier formation since ablation of GFAP-expressing astrocytes results in 
profound increases in the number of leukocyte infiltrates in the spinal cord of EAE mice 
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(Voskuhl et al., 2009). Thus, it is feasible to postulate that BLG sensitization stimulated 
peripheral immune cells and increased their circulating levels, and the perivascular 
astrocytes had become activated to regulate the amount of inflammatory influence from 
the periphery. To provide evidence for this notion, juxtaposition of leukocytes with 
GFAP-immunoreactive astrocyte end-feet across the blood vessel walls need to be 
demonstrated in our mouse model of CMA as shown in the EAE mice (Voskuhl et al., 
2009). Nonetheless, semi-quantitative analysis with western blotting showed that the 
GFAP levels in the midbrain regions were significantly elevated in BLG-sensitized mice 
when compared to sham mice (Figure 8), supporting our immunohistochemical 
observations. 
Astrocytes are multifaceted glia cells in the central nervous system, and they play 
essential roles in metabolic support, intercellular signaling, blood flow regulation, 
myelination, and synaptic pruning [reviewed by (Sofroniew and Vinters, 2010)]. It is of 
interest to examine whether these functions of astrocytes become dysregulated in BLG-
sensitized mice and influence their behavior. Astrocytes are also important mediators of 
neuroinflammation with the ability to produce and secrete pro- as well as anti-
inflammatory molecules (Eddleston and Mucke, 1993; John et al., 2003). The fact that 
the levels of TNFα were significantly elevated in the midbrain regions of the BLG-
sensitized mice suggested that the astrocytes were acting as proinflammatory mediators 
(Figure 10). However, it seems counterintuitive that microglia did not show reactive 
morphology in response to the elevated proinflammatory cytokine levels. One possible 
explanation is that TNFα detected in our samples had derived from the intestines or 
circulating leukocytes and was not produced by astrocytes, which had successfully 
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prevented the cytokine and cytokine-producing cells from activating microglia. An 
alternative explanation may be that our experimental paradigm was too transient, and 
BLG-sensitized mice needed to be repetitively challenged to elicit more chronic 
inflammation in order for microglia to become activated. These hypotheses, along with 
the possible involvement of other proinflammatory cytokines, such as IL-1β and IL-6, 
need to be tested in future studies. 
In conclusion, we have demonstrated that sensitization of C57BL/6J mice with 
BLG induces anxiety- and depression-like behaviors in male mice that are associated 
with decreases in tight junction proteins in the intestines and astrogliosis in the brain. 
Elevated TNFα levels in both of these locations suggest that this proinflammatory 
cytokine plays a role, at least in part, in mediating immune responses to the cow's milk 
allergen in sensitized mice. Whether these pathophysiological findings directly influence 
the behavior of sensitized mice is yet to be determined. However, clinical reports of 
symptom improvements in patients with treatment-resistant depression and other 
psychiatric conditions after elimination diet (Parker and Watkins, 2002) and 
plasmapheresis (Barzman et al., 2018) support the involvement of FAH-triggered 
immune responses in pathogenesis of behavioral disorders. Treatments with 
antihistamines and/or steroidal/non-steroidal anti-inflammatory reagents to, respectively, 
inhibit the effects of hypersensitivity-mediated immediate immune reactions (e.g., mast 
cell degranulation) and subsequent inflammation in our mouse model will be useful in 
clarifying the involvement of proinflammatory cytokines in the development of observed 
brain pathophysiology and behavioral changes. Elucidating the mechanisms by which 
immune responses to a dietary component manifest as brain and behavioral dysfunction 
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may therefore provide potential therapeutic approaches beyond the use of 
neuromodulatory drugs. 
Study 2 – Differential Myelination and Blood-Brain Barrier Associated 
Pathway Activation in Non-anaphylactic Model of Cow’s Milk Allergy  
Previous findings by us and others have characterized the behavioral phenotype 
arising from CMA (de Theije et al., 2014; Germundson et al., 2018; Smith et al., 2019; 
Smith et al., 2021). C57BL/6J mice are known to present mild symptoms compared to 
other mouse strains such as BALB/cJ and C3H mice which we observed here (Figure 11) 
(Smit et al., 2011; Marco-Martin et al., 2017; Smith et al., 2021). We have previously 
found no evidence of anaphylactic symptoms or allergen-induced hypothermia in 
C57BL/6J mice (Smith et al., 2021). Despite the lack of anaphylactic symptoms, they are 
routinely found to have elevated levels of allergen-specific IgE (Smit et al., 2011; 
Germundson et al., 2018; Smith et al., 2019; Smith et al., 2021). The mice generated for 
this study were treated similarly to those in our previous studies and have yielded 
consistent results (Figure 1); thus, behavioral testing was not performed with this group 
of animals.  
 Cytokines serve as likely mediators for peripheral to central signaling. BALB/cJ 
mice also presented with a robust behavioral phenotype and released large amounts of 
cytokines following allergen exposure (Marco-Martin et al., 2017; Smith et al., 2021). In 
addition, our previous observations with C57BL/6J mice implicated a TNFα mediated 
response causing astrogliosis and perivascular cuffing (Smith et al., 2019). Building off 
our CNS findings and cytokines profile seen in C57BL/6J mice following allergen 
challenge, we further validated those data by performing the same ELISA multiplex. 
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Despite not reaching the statistical significance threshold as previously observed with IL-
10, IL-13, and other cytokines (Figure 12), similar trends were observed. To validate this 
observation, greater sample numbers will be required. Though our significant cytokine 
findings show little overlap with previously published work, the heterogeneity in our 
system may be the result of differences in cytokine release similar to what was observed 
when comparing C57BL/6J and BALB/cJ mice. Therefore, there may be evidence of 
functional overlap between our previous findings of increased chemokines and IL-10, Il-
13, and IL-21 and roles of CCL24 and CXCL13 observed in this study. 
 Interestingly, despite evidence of gut barrier breakdown due to loss of occludin 
immunoreactivity (Smith et al., 2019), we observed no changes in the transcription of the 
tested factors or evidence of gut leakiness to FITC-dextran (Figure 13 and 14). The gut is 
the principal site of insult by CMA though we did not see evidence of permeability using 
this FITC-dextran approach, our model potentially does not yield a robust gut pathology 
or differing results may be achieved by adjusting our assay. 
The midbrain has routinely been one of the areas we observed histological 
changes, including astrogliosis and mast cell degranulation (Germundson et al., 2018; 
Smith et al., 2019). Therefore, it was interesting that IPA predicted changes in FMR1 
activity (Figure 15 and 18), decrease in myelin and lymphocyte protein (MAL) and 
proteolipid protein 1 (PLP1) transcription (Figure 18). The transcription of the iron 
transporter; transferrin was reduced. Transferrin is a central factor in the activity and 
differentiation of oligodendrocytes (Espinosa de los Monteros et al., 1999; Pérez et al., 
2013; Marziali et al., 2016). When performing our pathway analysis in the midbrain 
region, a clear association to the ALS signaling pathway supported the potential for 
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myelin degradation. Interestingly, the perivascular cuffing of astrocytes seen in our 
previous work is well documented in EAE (Voskuhl et al., 2009; Sofroniew and Vinters, 
2010). Regardless of the supportive association to myelin degradation pathways in IPA 
findings, we did not observe changes in myelination histologically when observed by 
MBP immunostaining, but there could be selective changes for other myelin proteins like 
the aforementioned MAL and PLP1. The iron transport dysfunction may have non-
oligodendroglial effects, could take more time to cause visible effects due to transferrin’s 
half-life of 8-10 days, or disruption of transferrin transcription does not impact already 
formed myelin.  
 Based upon pre-existing results in our model system that demonstrated 
perivascular astrocyte hypertrophy and TNFα accumulation in the midbrain, we 
suspected that blood-brain barrier integrity might be compromised (Smith et al., 2019). 
Evidence suggests that the brain is susceptible to the influx of immune cells and their 
products in inflammatory conditions (Rezai-Zadeh et al., 2009; Su and Federoff, 2014). 
Based on the observed reduction in Ocln transcription in our samples (Figure 19) and the 
predicted reduction in VEGFA in the pathway analysis (Figure 18), we assayed the 
permeability of the blood-brain barrier to serum IgG (Figure 21) (Hawkins and Davis, 
2005; Hawkins et al., 2007; Argaw et al., 2012). High amounts of IgG in the brain 
parenchyma and other blood-brain barrier permeability markers have been following 
peripheral immune responses resulting from TNFα signaling or other mast cell products 
(Cheng et al., 2018; Tran et al., 2019; Shelestak et al., 2020; Huang et al., 2021). We did 
not expect permeability to IgG to the scale we observed; the blood-brain barrier 
pathology is likely a central component of the mechanism causing the behavioral change 
138 
and immune cell infiltration. These data will be further validated with our research going 
forward as we continue to unveil the peripheral to central signaling cascade linking CMA 
to anxiety behavior. 
We were not able to investigate all the identified pathways in-depth, though they 
may serve as a foundation for future studies. The FcεRI had a positive z-score in the 
midbrain, which corresponds with our previously published studies showing mast cell 
degranulation. Though this project's focus was cytokine signaling, other mast cell factors 
are likely released by degranulation upon FcεRI activation. Across the midbrain and 
striatum/frontal cortex, signaling pathways involved in synaptogenesis, neurite 
development, axonic development, and netrin signaling were differentially activated. 
Changes in the activity of axonal, neurite, and synaptic development pathways all imply 
potential changes in neuronal morphology and connectivity. Neuronal morphology was 
outside the focus of this study but may be confirmed using general or selective neuronal 
immunohistochemical stain combined with a 3D structural scoring like a Sholl analysis 
(Sholl, 1953; Binley et al., 2014). Though histamine functions as a neurotransmitter, did 
not detect prediction of histamine signaling changes in our pathway analysis. Due to the 
crude dissection method used in our study, small transcriptional changes in confined 
regions might not have been detected with a great resolution. Because all histaminergic 
neurons are located in the tuberomammillary nucleus of the hypothalamus, transcriptional 
changes within this small nucleus might have been diluted by the inclusion of 
surrounding tissue (Scammell et al., 2019). In addition, the postsynaptic cells of the 
tuberomammillary nucleus are broadly scattered throughout the forebrain in the striatum, 
preoptic area, and prefrontal cortex; therefore, a high-resolution analysis may be required. 
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Despite the lack of detection for differences in histaminergic signaling, some CMA-
associated neuronal signaling pathways were identified by IPA. Most notably, the 
endocannabinoid and opioid signaling pathways have negative and positive activation z-
scores, respectively. Interestingly general G-protein coupled receptor subunit αs was 
increased in the striatum and frontal cortex sample. These signaling pathways warrant 
further investigation as they have document impacts on behavior. 
 In conclusion, we provided further support for a mechanism by which a non-
anaphylactic mouse model of CMA might elicit anxiety- and depression-like behavioral 
changes. BLG-sensitized mice were confirmed allergic by induction of BLG-specific IgE 
and lacked any apparent anaphylactic symptoms or health impact. The profile of plasma 
cytokines had considerable overlap with the profile previously observed in male 
C57BL/6J mice. The significantly increased BLG mouse cytokines and chemokines IL-
10, IL-13, CCL24, and CXCL13. Significant changes in brain transcriptome and 
histopathology were also observed. Our analysis suggested that Fmr1, Dio2, Slc16a2, and 
Sox2 likely drive the relevant pathways for the neuro and behavioral pathologies 
observed. In the midbrain, changes in myelination, anxiety, FcεRI, and vascular 
permeability were also predicted. These changes are likely important for the observed 
behavioral alterations in our BLG-sensitized mice.
140 
Study 3 – Anxiety-like Behavior and Intestinal Microbiota Changes as 
Strain- and Sex dependent Sequelae of Mild Food Allergy in Mouse 
Models of Cow’s Milk Allergy  
The severity and presentations of food allergy symptoms widely vary among 
individuals and likely contribute to inconsistencies across human cohort studies that 
investigate the association of food allergy with affective, behavioral, and cognitive 
disorders. Indeed, the heterogeneity in responses to allergens is often observed in human 
patients (Burks et al., 2012; Bird et al., 2015; Sicherer and Sampson, 2018; Fritscher-
Ravens et al., 2019). We postulated that the presence of allergy-associated behavioral 
manifestations would be influenced by sex and genetic background. In this study, we 
therefore used a mouse model of CMA to evaluate the effect of strain and sex on CMA-
associated anxiety-like behavior and cognitive function as well as physical reactions, 
immunological responses, and microbial changes.  
We first assessed whether the BLG sensitization regimen effectively induced 
CMA. Following an oral allergen challenge, both C57BL/6J and BALB/cJ strain mice 
showed no or mild observable reactions, scoring a severity level of 0-2 upon allergen 
challenge (Figure 22B). This outcome was not unexpected given that we and others have 
previously reported mild responses to allergen challenges with these strains (Marco-
Martin et al., 2017; Germundson et al., 2018; Smith et al., 2019), and C57BL/6 and 
BALB/c backgrounds are known to be more resilient to experimental allergic 
sensitization than other strains (Xu et al., 2018). However, greater numbers of BLG-
sensitized BALB/cJ mice scored 2 than sex- and treatment-matched C57BL/6J mice, 
rendering the modest differences in the clinical scores and body temperature from their 
respective sham groups statistically significant (Figure 22B, C). Mast cell-derived 
141 
histamine is a known contributor of allergy-induced hypothermia and respiratory distress, 
acting via H1/H2 histaminergic receptors. The absence of mast cells or histamine 
production in knockout mice, as well as histaminergic receptor antagonists in wild-type 
mice, have been shown to ameliorate these symptoms after inducing passive systemic 
anaphylaxis (Makabe-Kobayashi et al., 2002). Thus, our observation suggested that  
BLG-sensitized BALB/cJ mice were more susceptible to mast cell degranulation upon 
allergen challenge. As for the allergen-specific immunoglobulins, the sensitization-
induced changes in their levels did not closely mirror the physiological responses, and all 
BLG groups, except C57BL/6J females, showed small but significant increases in 
allergen-specific IgE (Figure 23A). Furthermore, IgG isotypes were also elevated in both 
male and female BALB/cJ mice after sensitization (Figure 23B and 23C). In contrast, we 
did not observe elevated IgG1 in the BLG groups of C57BL/6J mice. These results 
indicated that the production of allergen-specific immunoglobulin was differentially 
affected by the strain, particularly highlighting the difference in the amounts of IgG1 
production. However, we have previously observed elevated BLG-specific IgG1 in male 
and female C57BL/6J mice in our earlier study, in which mice were challenged twice, 1 
week apart (Smith et al., 2019). Thus, the number of allergen exposure and/or duration 
after sensitization may also affect the amounts of allergen-specific immunoglobulins.  
Despite the lack of anaphylaxis and other overt physical indications of severe 
allergic responses, BLG-sensitized C57BL/6J mice exhibited anxiety-like behavior one 
day after the allergen challenge. This CMA-associated behavior change was not observed 
in female C57BL/6J mice, an outcome in line with our previous study (Smith et al., 
2019). Although the results from the OF test were difficult to compare in BALB/cJ mice 
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due to their overall inactivity, the differences between sham and BLG mice were detected 
for male mice by the number of fecal pellets and EZM (Figure 24D and 25A-C). Again, 
these differences were not observed in BALB/cJ female mice, suggesting that females 
were less inclined to exhibit CMA-associated anxiety-like behavior regardless of strain. 
The cross-maze test did not show significant differences between sham and BLG mice in 
any of the groups or strain- or sex-dependent effects, suggesting that BLG sensitization 
followed by acute exposure to the allergen did not affect cognitive function, at least for 
spatial memory (Figure 26).  
Similar male-biased symptom manifestations have also been reported in human 
patients. Food allergy and certain types of behavioral conditions, such as ADHD and 
autism, are more commonly diagnosed in young males (Polanczyk et al., 2007; Kim et 
al., 2011; Pinares-Garcia et al., 2018). The sex-dependent dichotomy may be explained 
by the differences in the number of T lymphocytes and the presence of promoter elements 
within immune-related genes that can be regulated by sex hormones (DunnGalvin et al., 
2006; Markle and Fish, 2014; Klein and Flanagan, 2016; Laffont and Guery, 2019). In 
rodent studies, the contribution of estrogen to the regulation of anxiety-like behavior has 
also been investigated, although anxiolytic effects seem to depend on the dose of the 
hormone, behavior tests used, and age of mice (HayGlass et al., 2005; Boivin et al., 2017; 
Borrow and Handa, 2017). While it was outside the scope of our current study, 
identification of mechanistic or molecular factor(s) that protected our female mice from 
manifesting CMA induced anxiety-like behavior may provide potential therapeutic 
targets for anxiety.  
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Sex- and strain-specific variations were also found in the number, type, and levels 
of immune mediators detected in plasma, with male C57BL/6J mice showing the most 
number of analytes that were significantly altered with BLG sensitization, followed by 
male and female BALB/cJ mice (Figure 27A-C). No significant changes in plasma 
mediator levels were detected in female C57BL/6J mice, again underscoring the 
resilience of this group to the sensitization. In C57BL/6J males, increases in Th cells 
associated cytokines and chemokines were particularly notable. While the C57BL/6 and 
BALB/c strains are typically described to have Th1- and Th2- biased immune responses, 
respectively (Autenrieth et al., 1994; Nishimura et al., 1997; Mills et al., 2000; Watanabe 
et al., 2004), it has been argued that this generalization is based on infection models and 
does not apply to allergy paradigms (HayGlass et al., 2005). Our results also seemed to 
support this argument and did not categorize the responses of the two strains strictly into 
either Th1 or Th2. Instead, significant increases in IL-13 and IL-21 suggested that the 
responses of BLG-sensitized C57BL/6J mice were likely mediated by follicular helper T 
cells (Tfh), which are crucial for the production of IgE and other isotypes via 
differentiation of B cells (Gowthaman et al., 2019; Yao et al., 2020). 
The mediator responses by male C57BL/6J and BALB/cJ mice were clearly 
contrasting, with the former males showing increases in some mediators and the latter 
exhibiting decreases in a distinct set of mediators. In particular, sensitization-associated 
changes in IL-13 were observed in both strains but in opposite directions  
(Figure 27A, B). Although the functional significance of these CMA-induced differential 
changes in the analytes is yet to be determined, the elevation of IL-13 in C57BL/6J males 
likely facilitated the production of BLG-specific IgE. Concurrent increases in IL-10, 
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FGF2, CSF1, and CCL chemokines in C57BL/6J males also suggested that mobilization 
and/or proliferation of immune cells were prompted, triggering complex systemic pro- 
and anti-inflammatory responses in BLG-sensitized mice of this strain. It should be noted 
that some of these cytokines had been reported to be elevated in mouse models with more 
severe allergic reactions. For example, CCL1 and CCL17 were induced in the intestines 
of ovalbumin (OVA)-sensitized mice that developed diarrhea with mast cell infiltration 
(Knight et al., 2007), and high levels of CCL9 (MIP-1γ) was found in OVA-sensitized 
mouse lungs with increased airway resistance and eosinophil infiltrates (Rose et al., 
2010). These results suggested that, despite their lack of overt allergic reactions, BLG-
sensitized C57BL/6J mice elicited similar immune responses to those of other animal 
models of severe allergies, and thus, the absence of typical allergic reactions might not 
necessarily indicate the absence of hypersensitivity to the allergen. Following the same 
line of argument, the changes in the plasma mediators may not be accurate indicators of 
CMA-associated behavioral manifestations. As mentioned above, the cytokine profile of 
BALB/cJ male mice was conflicting with their C57BL/6J counterpart while both groups 
displayed anxiety-like behavior when assessed with the EZM test. In addition, a few of 
the inflammatory mediators were elevated in BALB/cJ female mice after sensitization 
(Figure 27C), but this group did not exhibit behavioral abnormalities, at least with the 
tests we performed.  
It may also be argued that the observed cytokine changes were reflective of 
different stress levels mice might have experienced from the behavior test one day before 
their blood was collected. Indeed, it has been shown that foot-shock stress increases the 
amounts of inflammatory cytokines in mice, including IL-10 and IL-13 (Cheng et al., 
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2015). However, the plasma levels of these cytokines reportedly return to the control 
levels after 24 hrs (Cheng et al., 2015), rendering the possibility that stress was a major 
contributor of the cytokine/chemokine changes less likely. Taken together, testing for the 
altered plasma levels of immune mediators may be more sensitive in detecting the 
development of allergen hypersensitivity than the presence of physical reactions, 
although it may not predict the presence of allergen-induced behavioral abnormality.  
We then postulated that intestinal microbiota would be altered following BLG 
sensitization procedure. Altered microbiota, or dysbiosis, has been reported in individuals 
with food allergy as well as with neuropsychiatric disorders (Tomova et al., 2015; 
Aizawa et al., 2016; Bunyavanich et al., 2016; Mangiola et al., 2016; Cenit et al., 2017; 
Savage et al., 2018). In addition, a growing amount of evidence supports that microbiota 
influences behavior and mood (Tomova et al., 2015; Aizawa et al., 2016; Mangiola et al., 
2016). Indeed, we found clear differences in beta diversity at the phylum level between 
sham and BLG-sensitized mice in all groups, although the most notable change with BLG 
sensitization was a marked decrease in Verrucomicrobia (Figure 28 and 29). While the 
number of observed species remained relatively unchanged (Figure 28A), Simpson index 
for C57BL/6J male mice indicated decreased biodiversity, supporting previous findings 
in humans that changes in alpha diversity was associated with milk allergy (Berni Canani 
et al., 2018; Shen et al., 2019). We further demonstrated that A. muciniphila was 
significantly lowered in the BLG-sensitized male C57BL/6J mice while its amount was 
increased in sham mice during the course of sensitization (Figure 30). This observation 
suggested that the colonization of the bacteria in the intestines was restricted during 
allergy development. A. muciniphila has been reported to be an important commensal 
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inhabitant that protects epithelial barrier integrity by regulating mucus production in the 
host (Reunanen et al., 2015). Furthermore, altered relative abundance of A. muciniphila 
has been found in obesity, diabetes, inflammatory bowel disease as well as neurological 
diseases such as Parkinson’s disease, and autism (Wang et al., 2011; Everard et al., 2013; 
Hill-Burns et al., 2017; Li et al., 2019; Xu et al., 2019). Thus, it is possible that the lack 
of A. muciniphila is associated with anxiety-like behavior and/or other behavioral 
manifestations. Further studies in which the amounts of intestinal A. muciniphila are 
experimentally manipulated prior to behavior testing will confirm this association. Our 
KEGG Pathway analysis further supported that the microbiome changes observed in 
BLG-sensitized male C57BL/6J mice likely influenced neurological functions, including 
those involved in Parkinson’s disease and dopaminergic and serotonergic synapses 
(Figure 31). These pathways consist of many molecular interactions between enzymes, 
receptors, channels, transporters, etc., and therefore it is necessary to validate the 
involvement of specific pathway components that were indeed affected by the 
sensitization-induced dysbiosis. This extrapolated bioinformatics approach, however, 
provides valuable information in narrowing down potential targets for further 
investigation in our future studies.  
Taken together, our results demonstrated some significant sex- and strain-
dependent differences in the symptom presentations of experimentally induced CMA in 
mice, with males of both strains having the propensity to display anxiety-like behavior. 
Other sensitization-associated differential presentations included serum levels of 
allergen-specific IgE/IgG, plasma levels of immune mediators, and changes in microbiota 
compositions. We hereby provide evidence that the manifestations of hypersensitivity to 
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the same allergen are influenced by genetic variables in individuals, and therefore 
diagnosing food allergy by immediate reactions after allergen challenge and 
immunoglobulin levels may exclude a population of individuals with milder or atypical 
responses. In addition, stratification of allergic cohorts with additional diagnostic criteria 
may reduce apparent inconsistencies in human studies.
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Limitations of Work Presented in this Dissertation  
The research presented in this dissertation highlights the causal role of CMA and 
various behavioral observations in a non-anaphylactic mouse model. Limitations of the 
work discussed in these studies are presented as follows. 
These data were generated in selective wild-type backgrounds of the C57BL/6J 
and BALB/cJ strains. These strains, as previously discussed, were chosen due to their 
archetypal nature of Th1 and Th2 immune biases (Autenrieth et al., 1994; Nishimura et 
al., 1997; Mills et al., 2000; Watanabe et al., 2004). Though the use of these inbred 
strains of mice removed the inherent genetic variability that has likely contributed to the 
conflicting results seen in human studies, applying these findings to heterogeneous 
populations is still necessary. However, the consistencies across the two distinct mouse 
backgrounds is a promising preliminary finding that may be further built upon using 
outbred mouse colonies. 
The measurement of allergen-specific IgE in the circulation is that it may not 
precisely reflect the total amount of the IgE produced by an allergic individual, since 
produced IgE becomes rapidly associated with high-affinity FcεRI on immune cells such 
as mast cells and basophils, and free IgE molecules are subjected to rapid degradation 
(Lawrence et al., 2017). Moreover, the serum samples we used in this study were 
prepared from the terminal blood, which was collected after 1 week from the last 
sensitization dose and 1-2 days from the allergen challenge (see Figure 1A). The half-life 
of IgE is estimated to be 2-3 days in humans (Lawrence et al., 2017) and 12 hours in mice 
(Vieira and Rajewsky, 1988), and thus, the amounts of IgE detected in our assay may 
have been an underestimation of actual amounts produced. Another limitation of our 
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current study was that IgG2a was measured as one of the allergen-specific 
immunoglobulins. However, C57BL/6J mice do not produce IgG2a but instead produce 
IgG2c isotype (Jouvin-Marche et al., 1989). For further assessments for allergen-induced 
immunoglobulin levels in this strain, an IgG2c-specific assay should be used.  
Despite evidence of gut barrier breakdown previously alluded to by loss of 
occludin immunoreactivity, we observed no changes in the transcription of the tested 
factors or evidence of gut leakiness to FITC-dextran. The gut is the principal site of insult 
for CMA, so the lack of a robust pathology is concerning; however, altering our approach 
may yield differing results. For example, we collected serum 5 hours after feeding FITC-
dextran, when some protocols have reported results with shorter collections (Woting and 
Blaut, 2018; Bordoni et al., 2019). Therefore, our mice might have cleared the FITC-
dextran before it was quantitated, which could also explain the high levels of variability 
of the FITC signal. 
 In our analysis of the brain, we broadly sectioned it into 4 regions. Despite the 
source of our RNA being from large heterogeneous regions of the brain containing many 
cell types and function regions, we still found differentially expressed genes. More genes 
may have been identified if we took a more directed approach or isolated specific cell 
types. For example, innovations in single-cell sequencing technologies, including Visium 
spatial gene expression, have seen great success and would allow for profiling RNA 
expression and mapping back onto histological sections (Maniatis et al., 2019; Mantri et 
al., 2021). Regardless a large number of regional differentially expressed genes were 
identified. To streamline our analysis, we performed pathway analysis and focused on 
changes of interest.  
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Summary of Conclusions and Future Directions  
The work presented in these studies characterize the systemic response resulting 
from non-anaphylactic CMA sensitized to the milk allergen BLG. BLG allergy within 
our model elicits varied responses depending on genetic background and sex. Universally 
in mice that exhibited anxiety- and depression-like behaviors, BLG-specific IgE was 
elevated. The intestinal impact of BLG allergy impacted gut health, causing dysbiosis. 
Breakdown on normal gut microenvironment likely exacerbated both the peripheral 
immune response and promoting behavioral changes. From the immune system's 
provocation, elevated circulation of various cytokines further promoted immune activity 
and likely acted as peripheral to central signaling molecules. Within the central nervous 
system, transcriptional changes for various signaling and overall health pathways were 
altered. Most interestingly, evidence of the breakdown of tight junctions and cellular 
function of the blood-brain barrier were noted. These findings were validated by 
prominent perivascular astrocyte hypertrophy and build-up of extravascular IgG in the 
midbrain, likely resulting or involved with the increase in TNFα release. 
Future work in this research area will continue fleshing out the molecular 
mechanism taking place within the brain. This will include further investigation of the 
exact role of mast cells, further characterizing the cellular morphology and signaling 
evidence established in this dissertation. We will also explore intervention strategies in 
the form of gut microbiota support with probiotics, mast cell suppressive mechanism, and 






Supplemental Figure 1.  An alternative analysis for the post-sensitization serum 
levels of BLG-specific IgE shown in Figure 4B. Serum 
isolated from the terminal blood was used to quantify the 
levels of BLG-specific IgE using ELISA. A group analysis 
including all sample values are shown in Figure 2B. As an 
alternative analysis of the results, outliers within each 
group were identified using GraphPad Prism software 
(ROUT, Q = 1%), and Mann-Whitney test was performed 
excluding the outlier values from the statistical analysis. 
For male groups, statistical significance of **p < 0.01 was 
found between sham and BLG mice (male sham: 0.10 ± 
0.02, n = 7; male BLG: 0.23 ± 0.05, n = 7; one outlier from 
each group was removed from the analysis [sham, 0.40; 
BLG, 2.37]). Statistically significant difference between 
female sham and BLG groups was not found using this 
method of analysis [female sham: 0.10 ± 0.01, n = 8; 
female BLG: 0.17 ± 0.06, n = 6; two outliers removed from 




Supplemental Figure 2.  Additional representative images of IgG immunoreactivity. 
The OD of IgG quantified extravascular IgG within the 
brain parenchyma (40 μm). Representative midbrain 
sections from sham (A, a', a”) and BLG-sensitized  
(B, b', b”) male mice are shown. Sections of the 
cerebellum (a’, b’) show areas where no difference in 
staining was observed across layers. Capillaries in cross-
section adjacent to the hippocampus (a”, b”) were 
observed to have differential staining along the wall of the 
blood vessel wall. The cerebellum sections (a’, b’) and 
capillary cross-section (a”, b”) images taken with 4X and 
40X objectives, respectively. Scale bars: 1 mm for (A) and 




Supplemental Figure 3. Serum levels of BLG-specific immunoglobulin isotypes. 
Terminal blood samples were used to detect BLG-specific 
serum IgE (A), IgG1 (B) and IgG2a (C) using ELISA. 
Optical density values at 450 nm were used to plot the 
graphs after subtracting the background values at 550 nm 
(OD450-550). Sham mice (open bars with open triangles); 
BLG mice (striped bars with filled diamonds); male 
C57BL/6J (blue); male BALB/cJ (red); female C57BL/6J 
(green); female BALB/cJ (orange). Bars indicate group 
average values in OD450-550 ± SEM (two-way ANOVA), 
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001,  
n = 10. 
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Supplemental Figure  4.  Time-dependent changes in the parameter measurements in 
the open-field activity monitoring. Overall activities of 
male (S4A) and female (S4B) sham and BLG-sensitized 
mice in an open-field arena were recorded for 10 min, and 
the activity parameters indicated in the y-axes were 
quantified by ANY-maze software. The values were 
graphed in relation to time in minutes (x-axis) during the 
test duration. Sham: open triangles; BLG-sensitized: filled 
diamonds. Values indicate group average ± SEM (t-test), 






Supplemental Figure 5. General locomotor activities recorded during the open-field 
activity monitoring. Total distance traveled and total time 
immobile were computed using ANY-maze software to 
assess potential effects of BLG sensitization on overall 
activities. Sham mice (open bars with open triangles); BLG 
mice (striped bars with filled diamonds); male C57BL/6J 
(blue); male BALB/cJ (red); female C57BL/6J (green) 
female BALB/cJ (orange). Bars indicate group average 
values ± SEM (two-way ANOVA), *p < 0.05, **p < 0.01, 




Supplemental Figure 6. Complete cytokine/chemokine array data using Quantibody 




Supplemental Figure 7. Extended diversity indices. In addition to the observed 
species, Chao1, Shannon, and Simpson indices were used 
to compare the diversity between sex-matched groups.
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Supplemental Figure 8.  Complete KEGG Pathway analysis performed based on the 
sensitization-induced microbiome changes. Tax4Fun2 
reference database was used to identify differential 
activation of pathways based upon changes in microbiome. 
Level 1 pathway classifications with an adjusted  
p-value < 0.05 (t-test with Bonferroni correction) and 
average log2 greater or less than 1 (fold changes greater or 











Supplemental Figure 9.  Complete microbiome profiles of all experimental groups. 
Found in Supplementary Data 6. of the following 




Supplemental Video 1. Male Sham mouse carefully walking across the open zone 





Supplemental Video 2. Male BLG mouse briefly surveying the open zone of the 
EZM and returning to the closed zone. Found in Video S2. 
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